PMS21 Determinants of Total Health Care Costs Associated With Rheumatoid Arthritis Prevalent Cases in Turkey (Englisch)
- Neue Suche nach: Baser, O.
- Neue Suche nach: Burkan, A.
- Neue Suche nach: Baser, E.
- Neue Suche nach: Koselerli, R.
- Neue Suche nach: Ertugay, E.
- Neue Suche nach: Altinbas, A.
- Neue Suche nach: Baser, O.
- Neue Suche nach: Burkan, A.
- Neue Suche nach: Baser, E.
- Neue Suche nach: Koselerli, R.
- Neue Suche nach: Ertugay, E.
- Neue Suche nach: Altinbas, A.
In:
VALUE IN HEALTH
;
15
, 7
;
A442-A443
;
2012
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:PMS21 Determinants of Total Health Care Costs Associated With Rheumatoid Arthritis Prevalent Cases in Turkey
-
Beteiligte:Baser, O. ( Autor:in ) / Burkan, A. ( Autor:in ) / Baser, E. ( Autor:in ) / Koselerli, R. ( Autor:in ) / Ertugay, E. ( Autor:in ) / Altinbas, A. ( Autor:in )
-
Erschienen in:VALUE IN HEALTH ; 15, 7 ; A442-A443
-
Verlag:
- Neue Suche nach: Blackwell Publishing Ltd
-
Erscheinungsdatum:01.01.2012
-
Format / Umfang:A442-A443
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 610
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 610 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 15, Ausgabe 7
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- A278
-
PR2 Guiding Principles for Providing Effective Access to Medicines in Emerging MarketsShankar, R. / Hickson, S. et al. | 2012
- A282
-
MO2 Impact of Structural Assumptions on Cost-Effectiveness Outcomes: Towards a Standardized Cost-Effectiveness Model for Adjuvant Breast Cancer TherapiesFrederix, G. W. / Van hasselt, J. G. / Schellens, J. H. / Hö / vels, A. M. / Huitema, A. D. / Raaijmakers, J. A. / Severens, J. et al. | 2012
- A283
-
PA3 Limited Access to Cataract Surgery in PolandSzmurlo, D. / Fundament, T. / Kopec, G. / Brzyski, D. / Wladysiuk, M. / Landa, K. et al. | 2012
- A285
-
CL2 Statistical Considerations in Estimating Survival for Economic Evaluations in OncologyKhan, N. / Shah, D. / Briggs, A. / Park, J. / Huang, H. / Hawkins, N. et al. | 2012
- A286
-
DU3 Market Access Delays for CNS Drugs in EuropeFlostrand, S. J. / Anderson, L. / Esposito, G. et al. | 2012
- A287
-
RE4 Beyond the Evidence - The Influence of Decision Processes on Outcomes in Coverage Determination of Health TechnologiesFischer, K. E. / Rogowski, W. H. / Leidl, R. / Stollenwerk, B. et al. | 2012
- A288
-
PHP1 Incorporating the Patient's Voice Into the Assessment of Medical Devices: A Comparison of the United States and EuropeDoward, L. / Whalley, D. / Houghton, K. / DeMuro, C. / Evans, E. / Gnanasakthy, A. et al. | 2012
- A289
-
PHP7 How Do Reimbursement Systems Encourage or Inhibit Adoption of Innovative Medical Devices in an Ambulatory Setting?Wilkinson, G. / Drummond, M. et al. | 2012
- A290
-
PHP12 Patented Drug Extension Strategies on Health Care Spending: A Cost-Evaluation AnalysisVernaz, N. / Haller, G. / Girardin, F. / Huttner, B. / Dayer, P. / Muscionico, D. / Salomon, J. L. / Bonnabry, P. et al. | 2012
- A291
-
PHP18 The Effect of Law for Economical Use of Medications 2006 on the Catchment Population of Community Pharmacies Between 2007-2010Boncz, I. / Donka-Verebes, x. / Oberfrank, F. et al. | 2012
- A292
-
PHP23 The Early Benefit Assessment of New Pharmaceuticals in Germany (“AMNOG”): A Structured Survey Analysis One Year After EnactmentStoeckel, F. / Neubauer, A. S. et al. | 2012
- A294
-
PHP34 France Market Access: Review of 2011-2012 Assessments by Transparency CommitteeAggarwal, S. et al. | 2012
- A295
-
PHP39 Explaning Differences in EU5 Market Penetration Levels and Rates of Biosimilars: The Case of Epoetine, Granulocyte-Colony Stimulating Factor, and Growth HormonesFrenzel, A. / Schmidt, N. / Grahl, J. et al. | 2012
- A297
-
PHP51 Perception of Parallel Trade of Pharmaceuticals in Poland – Results of National Market ResearchBaran-Lewandowska, I. / Hermanowski, T. et al. | 2012
- A298
-
PHP57 Emerging Drug Reimbursement Models: Lessons and Implications from Cancer Drug Access SchemesAggarwal, S. et al. | 2012
- A299
-
PHP63 Potential Effects of Changes in Pricing Regulations Between 2004 and 2011 on the Turkish Pharmaceutical IndustryMemis, S. A. / Deger, C. / Marmarali, B. / Parali, E. / Sumer, F. / Karakeben, K. / Kayadibinli, M. / Cetinelli, S. T. et al. | 2012
- A300
-
PHP68 The Effect of Resetting the Clock in Health CareGresz, M. / Varga, S. / Sebestyé / n, A. / Toldi, J. / Bogá / r, L. / Molics, B. / Boncz, I. et al. | 2012
- A301
-
PHP74 Cost-of-Illness of Patient-Reported Adverse Drug Events – a Population-Based SurveyGyllensten, H. / Rehnberg, C. / Jö / nsson, A. K. / Petzold, M. / Carlsten, A. / Andersson Sundell, K. et al. | 2012
- A303
-
PHP86 Cost-Effectiveness in Health Care Programs: A Literature ReviewVanhaute, O. A. / Annemans, L. et al. | 2012
- A304
-
PHP91 Is There an Overuse of Computed Tomography (CT) Scanning of Patients in United States Hospitals? A Review of the EvidenceWang, Z. / Boswell, E. / Kokkotos, F. K. / Dong, X. / Liu, Y. / Tong, H. / Xiao, H. et al. | 2012
- A305
-
PHP97 The Regional Distribution of Disabled Pensioners of HungaryTurcsanyi, K. / Pakai, A. / Szabó / J. / Olá / h, A. / Gombos, G. / Gresz, M. / Molics, B. / Boncz, I. et al. | 2012
- A306
-
PHP102 Patient Satisfaction with Pharmacies ConditionRasekh, H. / Rangchian, M. / Mehralian, G. / Bagherian, S. J. et al. | 2012
- A307
-
PHP107 Experts' Views on the Introduction of a Monopsony in Health Care Services in GreeceSkroumpelos, A. / Zavras, D. / Pavi, E. / Kyriopoulos, J. et al. | 2012
- A309
-
PHP118 Estimating the Probability of a Recommendation for Reimbursement for a New Drug in the UK Using an MCDA ApproachWilliams, P. / Mauskopf, J. A. / Kilburg, A. / Lebiecki, J. et al. | 2012
- A310
-
PHP124 Comparison of HTA Dossier Requirements Across EuropeCasamayor, M. / Van Engen, A. et al. | 2012
- A311
-
PHP130 Guidelines Without Guidance: The Case of Epidemiological Data Beyond Clinical TrialsSandmann, F. G. / Herrmann, K. H. / Zhou, M. / Gerber, A. / Lhachimi, S. K. et al. | 2012
- A312
-
PHP135 Stakeholders's Views of the Social Insurance Reform in GreeceMylona, K. / Skroumpelos, A. / Tsiantou, V. / Karampli, E. / Pavi, E. / Kyriopoulos, J. et al. | 2012
- A313
-
PHP141 Effects of Changing Health Policy on Pharmacoeconomics and Health Outcome Studies in TurkeyKockaya, G. / Daylan Kockaya, P. / Ergin Oguzhan, G. et al. | 2012
- A314
-
PHP146 Pharmacoeconomic Education for Pharmacy Students in the Russian FederationMakhinova, T. / Makhinova, E. N. / Rascati, K. L. et al. | 2012
- A315
-
PHP152 The Early Benefit Assessment of Drugs That are Launched Before 2011Weber, B. et al. | 2012
- A316
-
PHP157 To What Extent Does the Federal Joint Committee Follows the Evidence Based Recommendations by IQWiGWeber, B. / Schmitter, S. / Schiffner-Rohe, J. et al. | 2012
- A317
-
PHP162 Review of NICE's Technology Appraisal RecommendationsRinaldi, F. / George, E. / Longson, C. et al. | 2012
- A318
-
PHP169 Comparing the Hungarian Methodological Guideline for Conducting Economic Evaluation of Health Care Intervention with European GuidelinesHuszti, Z. / Nagy, B. Z. et al. | 2012
- A319
-
PHP174 Physical Activity Matters: The Associations Between Body Mass Index, Physical Activity and Health-Realted Quality-of-Life Trajectories Over 10 YearsFeeny, D. H. / Garner, R. / Bernier, J. / Thompson, A. / Mcfarland, B. H. / Huguet, N. / Kaplan, M. S. / Ross, N. A. / Blanchard, C. et al. | 2012
- A322
-
PHP190 Global Pharmaceutical Risk-Sharing Agreement Trends in 2011 and 2012: Slowing Down?Ando, G. / Izmirlieva, M. / Honoré / A. C. et al. | 2012
- A323
-
PHP195 Adoption of New Technologies in Twenty Established and Emerging MarketsHertz, D. / Marcarelli, A. D. / Patel, L. / Garfield, S. et al. | 2012
- A324
-
PHP201 Can Risk Management Plans (RMP) Contribute to Health Technology Assessment (HTA) and Knowledge of Safety in Everyday Medical Practice?Prieto, L. / Spooner, A. / Hidalgo-Simon, A. / Rubino, A. / Kurz, X. / Arlett, P. et al. | 2012
- A325
-
PHP206 Assessing the Value of Access to Individual Patient Data for Reimbursement DecisionsManca, A. et al. | 2012
- A326
-
PGI5 Effectiveness and Safety of Antacids in Pregnant Women Suffering From Gerd/Hyperacidity SymptomsDonde, S. et al. | 2012
- A328
-
PGI18 Cost-Effectiveness of Boceprevir in Combination With Pegylated Interferon Alfa and Ribavirin for the Treatment of Genotype 1 Chronic Hepatitis C: Submission to the National Institute for Health and Clinical Excellence (NICE)Humphreys, S. C. / Elbasha, E. H. / Ferrante, S. A. / Lion, M. / O'Regan, C. et al. | 2012
- A329
-
PGI23 Cost-Effectiveness of Episodic or Maintenance Infliximab Versus Standard Treatment in an Incidence Cohort of Crohn's Disease Patients With 10-Years Follow-UpOdes, S. / Greenberg, D. / Vardi, H. / Friger, M. / Stockbrugger, R. / Munkholm, P. et al. | 2012
- A330
-
PGI27 Impact of Linaclotide Treatment on Work Productivity and Activity Impairment in Adults With Irritable Bowel Syndrome With ConstipationBuono, J. L. / Tourkodimitris, S. / Sarocco, P. / Baird, M. J. / Johnston, J. M. / Carson, R. et al. | 2012
- A331
-
PGI32 New Antiviral Drugs for Hepatitis C in Italy: Will it be a Treasure Hunt?Gardini, I. / Fontana, R. / Fumagalli, M. / Conforti, M. / Lanati, E. P. et al. | 2012
- A332
-
PGI37 Finalisation and Psychometric Validation of a new Questionnaire Measuring Patient Satisfaction With Anti-TNF Treatments in Severe Crohn's DiseaseArnould, B. / Fofana, F. / Gilet, H. / Colombel, J. F. / Faure, P. / Hagè / ge, H. / Nachury, M. / Nahon, S. / Tucat, G. et al. | 2012
- A333
-
PMH2 Interim Results From the “AUTOR” Study, a European Observational Study in Pediatric Patients With Attention Deficit/Hyperactivity Disorder: Patient Characteristics and 1-Year CostsHaynes, V. / Quail, D. / Lorenzo, M. / Deix, C. / Anand, H. et al. | 2012
- A334
-
PMH8 Cost of Methylphenidate and Atomoxetine Prescribing to Children and Adults in South AfricaTruter, I. et al. | 2012
- A335
-
PMH13 Longitudinal Analysis of Patient Level Health Care Costs in Patients With Major Depressive Disorder Treated With DuloxetineCui, Z. / Faries, D. E. / Shen, W. / Able, S. L. / Novick, D. et al. | 2012
- A336
-
PMH18 Treatment Patterns and Costs in Patients With Schizophrenia in GermanyZeidler, J. / Heres, S. / Mahlich, J. C. / Greiner, W. et al. | 2012
- A337
-
PMH23 A Cost-Effectiveness Analysis of the Long-Acting Antispychotic Drugs Paliperidone Palmitate, Olanzapine Pamoate and Risperidone in the Treatment of Schizophrenia in FinlandEinarson, T. R. / Pudas, H. / Zilbershtein, R. / Jensen, R. / Nielsen, A. T. / Piwko, C. / Hemels, M. / Vincente, C. et al. | 2012
- A338
-
PMH28 Using Cost-Effectiveness Analysis to Define the Optimal Group of Patients to Benefit From Risperidone Long-Acting InjectableValencia-Mendoza, A. / Herná / ndez-Garduñ / o, A. et al. | 2012
- A339
-
PMH33 Cost Effectiveness of Paliperidone Palmitate Versus Oral Medication in the Treatment of Schizophrenia in AustriaWalter, E. / Dragosits, A. / Said, M. et al. | 2012
- A340
-
PMH38 Assessing Depressive Symptoms in Primary Care: Psychometrical Properties of the Spanish Version of the Clinically Useful Depression Outcome ScaleAgü / era, L. / Monton, C. / Maurino, J. / Medina, E. / Diaz, H. / Cuervo, J. et al. | 2012
- A341
-
PMH43 Modelling the Longitudinal Latent Effect of Pregabalin on Self-Reported Changes in Sleep Disturbances and Disability in Outpatients With Generalized Anxiety Disorder (GAD) Treated in Routine Clinical Practice in SpainRuiz, M. A. / Alvarez, E. / Carrasco, J. L. / Olivares, J. M. / Pé / rez, M. / Rejas, J. et al. | 2012
- A342
-
PMH48 Public Beliefs and Attitudes About Schizophrenia, Major Depression and Psychotropic MedicationRefaï / T. / Millier, A. / Toumi, M. / Ré / muzat, C. / Angermeyer, M. C. et al. | 2012
- A343
-
PMH54 ADHD Among Adults in Five Western European Countries: An Analysis of National Health and Wellness Survey DataAble, S. L. / Haynes, V. / Annunziata, K. / Upadhyaya, H. / Deberdt, W. et al. | 2012
- A344
-
PMD1 Economic Value of Screening for Early Parkinson's Disease in a European SettingJohnson, S. / Birnbaum, H. G. / Kaltenboeck, A. / Diener, M. / Siderowf, A. et al. | 2012
- A345
-
PMD6 Extracorporeal Photopheresis for the Treatment of Patients With Acute or Chronic Graft Versus Host Disease (GvHD), Refractory to Corticosteroids – A Sytematic ReviewWalczak, J. / Miernik, K. / Kuter, I. / Ussowicz, M. et al. | 2012
- A346
-
PMD12 A Budget Impact Model to Investigate Potential Cost Savings Associated With the Use of Safety-Engineered Sharp Devices in BelgiumHanmore, E. / Ruff, L. / Maclaine, G. D. / Garin, F. / Leroy, N. et al. | 2012
- A347
-
PMD17 Use of Sterrad® Sterilizers Results in Cost-Savings Compared to Steam Sterilization in an Italian Hospital SettingPerrone, F. / Zenna, G. / Mauro, E. / Hamerslag, L. / Emmermann, A. et al. | 2012
- A349
-
PMD28 Comparing the Cost and Diagnostic Efficiency of Gadoxetic Acid-Enhanced MRI Versus Extracellular Contrast Media-Enhanced MRI and Multidetector Computed Tomography in Patients With Suspected Hepatocellular Carcinoma in Thailand and KoreaHoltorf, A. P. / Bergmann, K. / Kim, M. J. / Phongkitkarun, S. / Sobhonslidsuk, A. / Rinde, H. / Lee, J. M. et al. | 2012
- A350
-
PMD33 The Impact of Three Different Imaging Strategies on Surgery Planning for Patients With Colorectal Cancer Liver MetastasesRinde, H. / Zech, C. J. / Jonas, E. / Bergmann, K. / Holtorf, A. P. et al. | 2012
- A351
-
PMD38 The Cost Burden of Unexplained Syncope in Five European Countries: A Database AnalysisEggington, S. / Tsintzos, S. / Collignon, C. / Borghetti, F. / Martí / B. / Sicras-Mainar, A. et al. | 2012
- A352
-
PMD44 Evaluating Strategies for Using DNA Testing to Identify Mucinous Pancreatic CystsMyers, J. A. / Klein, R. W. / Han, X. / Al-Haddad, M. A. / Smolen, H. J. et al. | 2012
- A354
-
PMD55 Sacral Nerve Modulation (SNM) for the Treatment of Idiopathic Refractory Overactive Bladder: Cost-Effective in the UK Compared to Optimal Medical Therapy, Botulinum Toxin a (BoNT-A) and Percutaneous Tibial Nerve Stimulation (PTNS)Walleser, S. / Betts, C. / Hallas, N. / Ockrim, J. et al. | 2012
- A355
-
PMD61 Cost-Effectiveness of Positron Emission Tomography in Head and Neck Squamous Cell Carcinoma: A Systematic ReviewZaim, R. / Redekop, W. K. / De Bree, R. / Van Dongen, G. A. / Hoekstra, O. S. / Uyl-de Groot, C. A. et al. | 2012
- A357
-
PMD72 The Use of Multi-Criteria Decision Analysis to Elicit Colorectal Cancer Screening PreferencesHummel, J. M. / Steuten, L. / Groothuis-Oudshoorn, K. G. / Mulder, N. / IJzerman, M. J. et al. | 2012
- A358
-
PMD77 Contribution of Individual EQ-5D Dimensions to Improved Quality of Life After Balloon Kyphoplasty for Vertebral Compression FracturesBorgströ / m, F. / Aghayev, E. / Olafsson, G. / Miltenburger, C. et al. | 2012
- A359
-
PMD82 Implantable Cardioverter Defibrillator in Italy From 2000 to 2008: A Population-Based Analysis Using Health Administrative DatabasesMadotto, F. / Fornari, C. / Conti, S. / Borghetti, F. / Mantovani, L. G. / Cesana, G. et al. | 2012
- A360
-
PMD88 Disparities in Access to EGFR-Mutation Testing in Patients With Advanced NSCLC in Germany 2011Kellermann, L. / Ukena, D. et al. | 2012
- A362
-
PCV6 Comparison Rivaroxaban with Other Antithrombotic Agents: Effectiveness and Safety of Prophylactic Antithrombotic Agents After Major Orthopedic Surgeries in TaiwanChang, W. Y. / Hsu, H. C. / Wu, C. H. / Chen, P. S. / Wu, M. T. et al. | 2012
- A363
-
PCV11 Indirect Treatment Comparison (ITC) of Novel Oral Anticoagulants for the Prevention of Thromboembolic Events in Patients With Atrial FibrillationPechlivanoglou, P. / Le, H. H. / Engelfriet, P. M. / Redekop, W. K. / Postma, M. J. et al. | 2012
- A364
-
PCV16 Use of ACE Inhibitors in Serbia in 2009 and 2010Milijasevic, B. / Tomic, Z. / Sabo, A. / Horvat, O. et al. | 2012
- A365
-
PCV22 A Simple Risk Score Identifies Individuals, in European Settings, More Likely to Incur Higher Medical CostsGuda, S. / Alperin, P. / Schuetz, C. A. et al. | 2012
- A366
-
PCV27 Pharmacoeconomic Evaluation of Neuroprotective Therapy of Patients With Acute Ischemic Stroke in UkraineMishchenko, O. / Iakovlieva, L. / Adonkina, V. / Chinush, I. / Matyashova, N. et al. | 2012
- A367
-
PCV32 The Cost of Diabetes Complications in BelgiumLamotte, M. / Chevalier, P. et al. | 2012
- A369
-
PCV43 Fair Cost-Benefit Evaluation of Health Care: A Case Study of Blood Pressure Lowering Drugs in FranceDormont, B. / Fleurbaey, M. / Luchini, S. / Samson, A. L. / Schokkaert, E. / Thé / baut, C. / Van de Voorde, C. et al. | 2012
- A370
-
PCV48 Systematic Review of Cost-Effectiveness Models for Pharmacologic Stroke Prevention in Atrial FibrillationLimone, B. / Baker, W. L. / Roberts, M. / Coleman, C. I. et al. | 2012
- A371
-
PCV53 Economic Evaluation of a Single Pill Triple Antihypertensive Therapy With Valsartan, Amlodipine, and Hydrochlorothiazide Against Its Dual Components in GreeceStafylas, P. / Kourlaba, G. / Hatzikou, M. / Georgiopoulos, D. / Maniadakis, N. et al. | 2012
- A373
-
PCV65 A Health Economic Evaluation of Omega-3 Acid Ethyl Esters 90 in the Secondary Prevention Post-MIGerlier, L. / Vellopoulou, K. / Lamotte, M. / Lacey, L. / Einroos, A. / Carr, E. et al. | 2012
- A374
-
PCV70 Cost-Effectiveness of Smoking Cessation Interventions in Smokers With Cardiovascular Disease in the NetherlandsMajer, I. M. / Rozenbaum, M. H. / Verheggen, B. et al. | 2012
- A376
-
PCV82 Observational Study Evaluating the Level of Compliance With Antihypertensive Drugs in the Greek PopulationGeorgiopoulos, D. / Hatzikou, M. / Demousis, F. / Sakalides, C. et al. | 2012
- A377
-
PCV87 Factors Related to Non-Adherence and Satisfaction for Hypertension Medications: Results From a Novel Patient RegistryKamble, S. / Cascade, E. / Gemmen, E. et al. | 2012
- A378
-
PCV92 Comparison of the Psychometric Properties of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) and the SF-36 in Patients with Pulmonary HypertensionTwiss, J. / Ganderton, L. / Jenkins, S. / Ben-L'amri, M. / Gain, K. / Fowler, R. / Gabbay, E. / McKenna, S. et al. | 2012
- A379
-
PCV97 Burden of Dyspepsia among Patients With Atrial Fibrillation in JapanKinoshita, Y. / DiBonaventura, M. D. / Wang, E. C. / Rossi, B. / Iwamoto, K. / Stankus, A. / Briere, J. B. et al. | 2012
- A380
-
PCV102 Characteristics Influencing Japanese Atrial Fibrillation Patients Preferences for Anticoagulants UseOkumura, K. / Inoue, H. / Yasaka, M. / Gonzalez, J. M. / Hauber, A. B. / Iwamoto, K. / Wang, E. C. / Rossi, B. / Briere, J. B. et al. | 2012
- A381
-
PCV108 Analysis of Outpatient Utilization and Costs of Antithrombotic Drugs in Poland – Implications for Pharmaceutical Pricing and Reimbursement PolicyBochenek, T. / Nizankowski, R. et al. | 2012
- A382
-
PCV113 The Utilisation of Statins in Slovak RepublicGatialova, K. / Bellova, K. / Foltan, V. / Majtá / s, J. et al. | 2012
- A383
-
PCV119 Retrospective Analysis of Pharmaceutical Expenditures in 2011 in the Republic of SrpskaGuzvic, V. / Zah, V. et al. | 2012
- A385
-
PIN7 Efficacy of Ceftaroline Fosamil and Other Intravenous Antibiotics in the Treatment of Complicated Skin and Soft Tissue Infections (CSSTI): A Network Meta-Analysis (NMA)Medic, G. / Karabis, A. / Borrill, J. / Worrall, J. / Bergman, G. et al. | 2012
- A386
-
PIN12 Burden of Disease and Serotype Distribution Associated With Reportable Invasive Streptococcus Pneumoniae Pneumonia in Norway, 2007–2009Raluy, M. / Gray, S. / Lambrelli, D. / Eriksson, D. / Samantha, M. / Wasiak, R. / Myrvang, B. et al. | 2012
- A387
-
PIN17 Tuberculosis Treatment Outcomes in Four States of MalaysiaKhan, A. H. / Syed Sulaiman, S. A. / Abdul Muttalif, A. R. / Hassali, M. A. / Ahmad, N. et al. | 2012
- A388
-
PIN22 Economic Impact of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Persons Over 50 Years of Age With Underlying Chronic Medical Conditions in FinlandMartikainen, J. A. / Soini, E. J. / Laine, J. / hman, H. / Postila, V. / Klemets, P. et al. | 2012
- A390
-
PIN33 Corsar-Study (Cost and Resource Utilisation Study in Antiretroviral Treated Patients)Stoll, M. / Kuhlmann, A. / Hower, M. / Heiken, H. / Gerschmann, S. / Klauke, S. / Lutz, T. / Bogner, J. / Degen, O. / van Lunzen, J. et al. | 2012
- A391
-
PIN38 Real Life Study of Antifungal Treatment in Greek ICUs: Therapeutic Strategy and Hospital Resource Utilization – Estimator StudyArmaganidis, A. / Nanas, S. / Antoniadou, E. / Mandragos, K. / Liakou, K. / Kostagiolas, L. / Koutsoukou, A. / Baltopoulos, G. / Nakos, G. / Magkina, A. et al. | 2012
- A392
-
PIN43 The Use of Futility Rules in Economic Evaluations With Direct Acting Agents (DAA) in the Treatment of Genotype 1 Hepatitis C Virus (HCV) From a Spanish Health Care PerspectiveD'Angelo, E. R. / Garcia Gonzalez, I. / Simon, M. A. et al. | 2012
- A393
-
PIN48 Cost-Efectiveness Analysis of Darunavir Versus Atazanavir, Each in Combination With Emtricitabine and Tenofovir, for the Management of Naive Anti-Retroviral HIV Infected Patients, Under the Belgian Social Security PerspectiveSantos, M. / Stenut, S. / Ferraq, W. / Legrand, J. C. / Tilleul, P. / Borget, I. et al. | 2012
- A394
-
PIN53 The Cost Effectiveness of Maternal and Infant Antiretroviral Regimens to Prevent Vertical Transmission in a Resource Poor CountryRevill, P. / Walker, S. / Sculpher, M. J. / Merry, C. / Barry, M. / Ryan, M. et al. | 2012
- A395
-
PIN59 Cost-Effectiveness of Amoxicillin Clavulanate Directed Towards the Application of Indicated at Primary Care in the Treatment of Community Acquired Pneumonia, Acute Rhinosinusitis, Tonsillopharyngitis, and Acute Otitis MediaMalhan, S. / Oksuz, E. / Eray, O. / Koc, E. et al. | 2012
- A396
-
PIN64 Assessing the Cost-Effectiveness (CE) of Vaccinating the Elderly and at-Risk Adults With the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) or no Vaccination (NoVac) in the UKJiang, Y. / Gauthier, A. / Keeping, S. T. / Carroll, S. M. et al. | 2012
- A397
-
PIN69 Cost Utility Analysis of 13-Valent Pneumococcal Conjugate Vaccine in MalaysiaWu, D. B. / Lee, K. K. / Lee, V. W. / Hong, L. W. / Roberts, C. S. et al. | 2012
- A398
-
PIN74 Cost Savings Due to Antibiotic Prescription Related to Quick C-Reactive Protein TestingTesar, T. / Babela, R. et al. | 2012
- A399
-
PIN80 Multivariate Cox Analysis Regarding Treatment Switch on Chronic Hepatitis B (CHB) Disease Management Based on a 2-Year Prospective Study in 5 European (EU) CountriesArama, V. / Zeuzem, S. / Leblebicioglu, H. / Simon, K. / Klauck, I. / Morais, E. / Lescrauwaet, B. / Kamar, D. / Zarski, J. et al. | 2012
- A401
-
PIN90 Towards Best Practices for Handling Uncertainties in Health Technology Assessments for HPV Vaccination to Better Inform Decision MakingSiebert, U. / Castellsague, X. / Lee Mortensen, G. / La Torre, G. et al. | 2012
- A402
-
PSU5 Bariatric Surgery From the Perspective of Brazilian National Health System (SUS)Freitas, M. G. / Souza, K. M. / Silva, M. T. / Elias, F. T. et al. | 2012
- A403
-
PSU10 Costs of Cardiovascular Readmissions Following Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease: Data From a Large Multi-Centre Australian RegistryAriyaratne, T. V. / Ademi, Z. / Duffy, S. J. / Andrianopoulos, N. / Billah, B. / Brennan, A. L. / Clark, D. J. / New, G. / Black, A. / Ajani, A. E. et al. | 2012
- A404
-
PSU15 Clinical and Economic Burden of Anastomotic Leaks After Colorectal SurgeriesLim, S. / Hammond, J. / Wan, Y. / Gao, X. / Patkar, A. et al. | 2012
- A405
-
PSU21 Sentinel Lymph Node Biopsy Less Expensive Than Axillary Lymph Node Dissection in Early Breast Cancer StagingRaimond, V. et al. | 2012
- A406
-
PSU26 Health-Related Quality of Life in Familial Amyloidotic Polyneuropathy Before and After Liver Transplantation: A Systematic Literature ReviewAmaral, L. M. / Fernandes, R. A. / Vasconcellos, J. F. / Takemoto, M. / Fujii, R. K. / Furlan, F. / Mould, J. et al. | 2012
- A407
-
PSU31 The Association Between Degenerative Disk Disease and Outcomes Among Patients Undergoing Lumbar Fusion SurgeryLage, M. J. / Kemner, J. E. / Mccormack, M. / Treglia, M. et al. | 2012
- A408
-
PCN1 Use of the 5-HT3-RA Antiemetics in the Prevention and Treatment of Radiation Induced Nausea and VomitingKnoth, R. L. / Faria, C. / Chang, E. / Broder, M. et al. | 2012
- A409
-
PCN6 The Evaluation of the Use and Effectiveness of Bevacizumab for Patients With Metastatic Renal Cell Carcinoma in Daily Practicede Groot, S. / Redekop, W. / Oosting, S. / Oosterwijk, E. / Kiemeney, L. / Uyl-de Groot, C. et al. | 2012
- A410
-
PCN11 The Impact of Treatment Persistence With Lenalidomide (LEN) for the Treatment of Multiple Myeloma (MM) on Disease ControlHenk, H. / Kaura, S. / Khan, Z. / Teitelbaum, A. et al. | 2012
- A411
-
PCN17 Indirect Comparison of the Efficacy of Erlotinib Versus Pemetrexed Plus Cisplatin as First Line Treatment in Patients With Metastatic Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor Activating MutationsPereira, C. / Sanches, M. / Loff, J. F. et al. | 2012
- A413
-
PCN29 Initial Treatment and Survival Among Elderly Patients With Advanced Breast Cancer by Estrogen Receptor and Progesterone Receptor Status: An Analysis of United States National Registry Data 2000-2009Lang, K. / Huang, H. / Namjoshi, M. / Federico, V. / Menzin, J. et al. | 2012
- A414
-
PCN34 Relationship Between Progression-Free Survival and Overall Survival in Chronic Lymphocytic LeukemiaBeauchemin, C. / Johnston, J. / Lapierre, M. E. / Aissa, F. / Lachaine, J. et al. | 2012
- A416
-
PCN45 Economic Evaluation of Using Branded Taxotere® Versus Generic Docetaxel: Based on Decision Tree ModelAl Ameri, M. N. / Tucker, A. / Johnston, A. et al. | 2012
- A417
-
PCN50 Treatment Patterns, Health Care Utilization, and Costs of Ovarian Cancer in Central and Eastern Europe Using a Delphi Panel Based on a Retrospective Chart ReviewKim, K. / Hernlund, E. / Justo, N. / Hernadi, Z. / Pete, I. / Ré / vé / sz, J. / Szá / nthó et al. | 2012
- A418
-
PCN56 Preliminary Results from a Study of Hospital Costs Due to Treatment of Head and Neck Cancers in EnglandTempest, M. J. / Thurston, S. / Carroll, S. M. / Keeping, S. T. et al. | 2012
- A419
-
PCN61 Melody Brazil – Resource Use and Associated Costs With Metastatic Melanoma in Brazilian Health Care SystemStefani, S. D. / Nita, M. E. / Nunes, J. / Campos, E. / Schmerling, R. A. / Barrios, C. / Dzik, C. / Alves, J. S. / Johnston, K. / Donato, B. M. et al. | 2012
- A420
-
PCN66 Cost-Effectiveness of Denosumab Versus Zoledronic Acid for Skeletal-Related Event (SRE) Reduction in Bone-Metastatic Prostate Cancer (mPC) in the UKBotteman, M. F. / Carter, J. A. / Fishman, P. / Chandiwana, D. / Bains, M. / Snedecor, S. J. et al. | 2012
- A421
-
PCN71 Cost-Effectiveness Analysis of Cetuximab and Panitumumab as First-Line Therapies for Metastatic Colorectal Cancer in SpainMoreno, V. / Martí / nez-Amores, B. / Barriuso, J. / Mezquita, L. / Ibá / ez de Cá / ceres, I. / Ayuso, x. / Peñ et al. | 2012
- A422
-
PCN76 Cost-Effectiveness of Erlotinib as First-Line Maintenance Therapy for Advanced Non-Small-Cell Lung Carcinoma in Patients EGFR WT and Stable Disease After Four Cycles of ChemotherapyCobo, M. / De Castro, J. / Isla, D. / Oyagü / ez, I. / Lozano, V. / Castro-Gomez, A. et al. | 2012
- A423
-
PCN81 Cost Effectiveness of Pazopanib in Soft Tissue SarcomaAmdahl, J. / Manson, S. / Isbell, R. / Chit, A. N. / Diaz, J. R. / Lewis, L. / Delea, T. E. et al. | 2012
- A424
-
PCN86 Cost-Effectiveness Analysis of Abiraterone for the Treatment of Advanced Prostate Cancer Under the Brazilian Private Health Care SystemPereira, M. L. / Bahmdouni, L. S. / Pepe, C. / Teich, V. et al. | 2012
- A426
-
PCN97 Pharmacoeconomic Analysis of the Prostate Cancer Therapy with Gonadotropin-Releasing Hormone Analogues: Leuprorelin, Goserelin, TriptorelinOmelyanovsky, V. / Avxentyeva, M. / Ivakhnenko, O. / Khailov, P. / Krysanov, I. / Maksimova, L. et al. | 2012
- A427
-
PCN102 The Cost of Absenteeism and Short-Term Disability Associated With Colorectal Cancer: A Case-Control StudyYaldo, A. / Seal, B. / Lage, M. J. et al. | 2012
- A428
-
PCN107 Persistence in First Line Treatment of Metastatic Renal Cell Carcinoma in Routine Care in GermanyMergenthaler, U. / Morawski, E. / Wendschlag, A. et al. | 2012
- A429
-
PCN112 Characteristics of Cancer Patients Who Seek Cytostatic Therapy in Korea: A Pilot StudyKim, E. H. / Park, S. / Lee, J. S. / Choi, H. S. / Kim, K. S. / Kim, S. / Choi, W. C. et al. | 2012
- A430
-
PCN117 Quality of Life in Patients With Malignant Ascites After Treatment With Catumaxomab: A Multicenter Phase II/III Study Comparing Paracentesis Plus Catumaxomab With Paracentesis AloneSalek, M. S. / Deger, M. / Wimberger, P. / Gilet, H. / Parsons, S. L. et al. | 2012
- A431
-
PCN122 Pilot Survey to Estimate Willingness to Pay (WTP) for Prophylactic Granulocyte Colony-Stimulating Factors (G-CSFs) Among Previously Treated Breast Cancer PatientsJohnson, P. / Bancroft, T. J. / Barron, R. / Legg, J. / Watson, H. / Naeim, A. / Watkins, A. / Marshall, D. et al. | 2012
- A432
-
PCN127 Policy Maker, Please Carefully Consider Your Needs: Does Outcomes Research of Bortezomib for Advanced Multiple Myeloma Reduce Uncertainty?Franken, M. G. / Gaultney, J. G. / Blommestein, H. M. / Huijgens, P. C. / Sonneveld, P. / Redekop, W. K. / Uyl-de Groot, C. A. et al. | 2012
- A433
-
PCN133 Utilisation of Antineoplatic Agents Involved in Treatment of NSCLC in Slovak Republic Within 2008-2011Bellova, K. / Gatialova, K. / Foltan, V. / Majtá / s, J. et al. | 2012
- A434
-
PCN138 Patterns of Anticoagulant Use in Cancer Patients Receiving ChemotherapyZong, J. H. / Eckert, L. / Zhang, L. / Dai, W. S. / Lyman, G. H. / Cohen, A. T. et al. | 2012
- A435
-
PCN143 Utility Data in Appraisals of Oncology Drugs by the UK National Institute for Health and Clinical ExcellenceProudfoot, C. et al. | 2012
- A436
-
PCN149 Uncertainty Regarding NICE's End-of-Life Small Patient Population CriteriaMoï / se, P. / Sweeney, N. / Holmstrom, S. et al. | 2012
- A437
-
PCN154 Are Population-Based Registries a Suitable Tool for Outcomes Research in Cancer? Experiences from Four Registriesde Groot, S. / Blommestein, H. / Franken, M. / Uyl-de Groot, C. et al. | 2012
- A438
-
PCN159 Melody Brazil - Treatment Patterns in Brazilian Health Care SystemSchmerling, R. A. / Barrios, C. / Nita, M. E. / Stefani, S. D. / Campos, E. / Nunes, J. / Biasi, L. / Lima, L. / Dzik, C. / Johnston, K. et al. | 2012
- A439
-
PMS5 Benefit-Risk Analysis of Adalimumab and Alternative Treatments for Moderate-to-Severe Rheumatoid ArthritisHicks, K. A. / Earnshaw, S. R. / Shaw, J. W. / Cifaldi, M. et al. | 2012
- A440
-
PMS10 Comparing Costs of Anti-TNF Therapy by Adminstration Route for Patients With Ankylosing Spondylitis and Rheumatoid Arthritis in France in 2012: A Budget Impact ModelChevreul, K. / Bourguignon, S. / Granados, D. et al. | 2012
- A442
-
PMS21 Determinants of Total Health Care Costs Associated With Rheumatoid Arthritis Prevalent Cases in TurkeyBaser, O. / Burkan, A. / Baser, E. / Koselerli, R. / Ertugay, E. / Altinbas, A. et al. | 2012
- A443
-
PMS26 Assessment of the Burden of Rheumatoid Arthritis in France: Analysis of a National Representative Claim DatabaseFagnani, F. / Laurendeau, C. / Fautrel, B. / Joubert, J. M. / De chalus, T. / Gourmelen, J. et al. | 2012
- A444
-
PMS31 Economic Evaluation of Adalimumab Versus Other Biologic Treatments for Moderate to Severe Psoriatic Arthritis in ItalyMarcellusi, A. / Bansback, N. / Rao, S. / Cifaldi, M. / Gitto, L. / Giannantoni, P. / Russo, S. / Mennini, F. S. et al. | 2012
- A445
-
PMS36 Cost-Effectiveness of Denosumab for the Treatment of Elderly Women With Post-Menopausal Osteoporosis in SwedenLundkvist, J. / Lö / thgren, M. / Badamgarav, E. / Freyschyss, B. et al. | 2012
- A446
-
PMS41 Cost-Effectiveness of Denosumab in Preventing Osteoporotic Fractures in Postmenopausal Women from the Private Health Care Setting Perspective in BrazilBarbosa, E. G. / Machado, M. / Araú / jo, G. T. / Etto, H. / Fonseca, M. / Olimpio, A. et al. | 2012
- A448
-
PMS52 Drug Use Profile in a Rheumatoid Arthritis Patient Cohort: A Brazilian Health Management Organization ExperienceCantanheda, C. R. / Simas, H. S. / Dias, Q. C. et al. | 2012
- A449
-
PMS57 Effect of Different Methods on Estimating Persistence to Oral Bisphosphonate Therapy in Portuguese PMO Patients – an Observational Prospective StudyGuerreiro, J. / Torre, C. / Mendes, Z. / Machado, M. / Ferreira, I. / Feudjo-tepie, M. / Canhã / o, H. / Branco, J. / Miranda, A. et al. | 2012
- A450
-
PMS62 Nominal Group Technique to Select Attributes for Discrete Choice ExperimentsHiligsmann, M. / Van durme, C. / Geusens, P. / Dellaert, B. / Dirksen, C. / Van der Weijden, T. / Reginster, J. Y. / Boonen, A. et al. | 2012
- A451
-
PMS67 Long-Term Benefits of 4-Weekly Certolizumab Pegol Combination and Monotherapy on Household Productivity and Social Participation in Rheumatoid Arthritis: 5 Year Results from an Open Label Extension StudyStrand, V. / Purcaru, O. / Van vollenhoven, R. / Choy, E. / Fleischmann, R. et al. | 2012
- A452
-
PMS72 Adherence and Change of Opioid Use After Initiating Duloxetine or Celecoxib Among Patients With OsteoarthritisPeng, X. / Wu, N. / Chen, S. Y. / Yu, X. / Andrews, J. S. / Novick, D. et al. | 2012
- A453
-
PMS77 Real-World Comparison of Health Care Utilization Between Duloxetine Initiators and Pregabalin Initiators Among Fibromyalgia PatientsPeng, X. / Sun, P. / Wu, A. / Andrews, J. S. / Novick, D. / Faries, D. / Sun, S. et al. | 2012
- A454
-
PMS82 US Treatment Patterns in Psoriatic Arthritis Newly Initiated on Etanercept or AdalimumabZhang, F. / Li, S. / Curtis, J. R. et al. | 2012
- A455
-
PUK5 Employment Rates and Indirect Costs in Patients With End-Stage Renal Disease: Differences Between Modalities of Renal Replacement TherapyJuliá / n, J. C. / Cuervo, J. / Rebollo, P. / Castejó / n, N. / Callejo, D. et al. | 2012
- A456
-
PUK10 Comparative Cost-Analysis of Six Anticholinergics for the Treatment of Overactive Bladder and Incontinence in GermanyMayrhofer, T. / Grabe, K. / Felder, S. et al. | 2012
- A457
-
PUK15 Sevelamer in Early Stages Nondialysis-Dependent Chronic Kidney Disease (NDD-CKD) Dominates Calcium Carbonate Through Reduction of Deaths and HospitalizationsRuggeri, M. / Di Iorio, B. et al. | 2012
- A458
-
PUK21 Conversion From Epoetin Alfa to Darbepoetin Alfa in Hemodialysis Patients With Chronic Kidney Disease: French Monocentre Observational StudyBinaut, R. / Bacri, J. L. / Fleury, D. / Maisonneuve, N. / Labatut, D. / Lemaitre, V. / Medeghri, Z. / Bir, G. / Lanier, J. et al. | 2012
- A459
-
PRM1 Kaplan-Meier Survival Curves: A Potential Source of Data for Systematic ReviewsGupta, J. / Bhutani, M. K. / Kumar, R. / Kaur, M. / Jindal, R. / Siddiqui, M. K. et al. | 2012
- A460
-
PRM6 The UK Contribution to Real World Research: Review of Published Data at ISPOR, Madrid 2011Peperell, K. / Lones, R. / Devlin, N. et al. | 2012
- A461
-
PRM11 Real-World Data to Calculate Cost-Effectiveness of Monoclonal Antibodies: Problems and Solutionsvan Rooijen, E. M. / van der Linden, N. / van Gils, C. / Oppe, M. / Uyl-de Groot, C. et al. | 2012
- A462
-
PRM16 Access to Cost Data Capture Using Public Database, Website and Literature in Germany, France, Spain and USAAlvarez-Ossorio, L. / Ezzat, N. / Cariou, Y. / Tarab, A. et al. | 2012
- A463
-
PRM22 The Headroom Method of Early Economic Evaluation of Medical Devices: A Useful Tool for Device Developers?Chapman, A. M. / Taylor, C. A. / Girling, A. J. et al. | 2012
- A464
-
PRM27 Evaluating European Data Sources for Assessing Real-World Effectiveness of New Anti-Diabetic DrugsMoï / se, P. / Andreykiv, M. / van Engen, A. / Wimbush, A. J. / Richards, A. / Ploug, U. J. et al. | 2012
- A465
-
PRM33 Real World Evidence: Promise and Pitfalls of Real World DataWeir, S. / Langham, S. / Ratcliffe, M. et al. | 2012
- A466
-
PRM38 Estimation of a Markov Chain for Crohn's Disease and Classification of Patients Into Disease Phenotypes, in Eight Countries Using Individual Longitudinal Data Aggregated Over TimeBorg, S. / Gerdtham, U. G. / Rydé / n, T. / Munkholm, P. / Odes, S. / Langholz, E. / Moum, B. / Annese, V. / Bagnoli, S. et al. | 2012
- A467
-
PRM43 A Systematic Review on the Application of Cardiovascular Risk Prediction Models in Pharmacoeconomics, With a Focus on Primary PreventionStevanovic, J. / Postma, M. J. / Pechlivanoglou, P. et al. | 2012
- A468
-
PRM48 The Half-Cycle “Correction”: How Much of a Correction is it?Taylor, M. / Lewis, L. et al. | 2012
- A469
-
PRM54 Correlating Cost Effectiveness Output With Patient Level Data Input via the IMS Core Diabetes Model (CDM)McEwan, P. / Foos, V. / Lloyd, A. / Palmer, J. L. / Lamotte, M. / Grant, D. et al. | 2012
- A470
-
PRM59 Methods for Discounting in Economic Evaluation; An Empirical Comparison of Preferences in Money and Quality of LifeParouty, M. / Krooshof, D. / Westra, T. / Postma, M. et al. | 2012
- A471
-
PRM65 A Minimal Information Decision-Analytic Approach to Early HTA of Diagnostic TestsKoffijberg, H. / Moons, K. G. / de Wit, G. A. et al. | 2012
- A472
-
PRM70 What If All Other Things are Not Equal? – Accounting for Future Changes in the Decision Context When Extrapolating Cost-Effectiveness Results Over TimeAsaria, M. / Palmer, S. et al. | 2012
- A473
-
PRM75 Parallel Sets as Interactive Visualization Approach for Analyzing Markov ModelsUrach, C. / Piringer, H. / Popper, N. / Breitenecker, F. et al. | 2012
- A475
-
PRM86 Utilizing Indirect Treatment Comparisons in Metastatic Castration Resistant Prostate Cancer (mCRPC)Wasiak, R. / Joulain, F. / Lambrelli, D. / Trask, P. C. / Sartor, O. et al. | 2012
- A476
-
PRM91 How Do Patients With Different Conditions Describe Their Pain?Martin, M. L. / Scanlon, M. / McCarrier, K. P. / Wolfe, M. / Bushnell, D. M. et al. | 2012
- A477
-
PRM96 Reliability of a Patient-Reported Adverse Drug Event Questionnairede Vries, S. T. / de Zeeuw, D. / Haaijer-Ruskamp, F. M. / Denig, P. et al. | 2012
- A478
-
PRM101 A Think Aloud Study Comparing the Validity and Acceptability of Discrete Choice and Best Worst Scaling MethodsWhitty, J. A. / Walker, R. / Golenko, X. / Ratcliffe, J. et al. | 2012
- A479
-
PRM106 Examination of Preferences Elicited From the General Public: Comparisons of Results From the Time Trade-Off and Standard Gamble InstrumentsIskedjian, M. / Navarro, V. / Farah, B. / Berbari, J. / Walker, J. H. / Lelorier, J. et al. | 2012
- A480
-
PRM111 Pediatric Patient-Reported Outcomes Assessment: A Case Study in Epidermolysis BullosaMordin, M. / Clark, M. / Doward, L. / Willian, M. K. et al. | 2012
- A481
-
PRM116 Payer and Patient Perceptions of Medication Value and the Role of Patient-Reported OutcomesCascade, E. / Andreykiv, M. / Istas, A. et al. | 2012
- A482
-
PRM122 Atopic Dermatitis on Families: Creation of a Specific Burden QuestionnaireMeni, C. / Bodemer, C. / Toulon, A. / Branchoux, S. / Taieb, C. et al. | 2012
- A483
-
PRM128 Development of a Translation Evidence Tracking Tool to Comply With the FDA Review Requirements for the Translation of PRO InstrumentsMear, I. / Anfray, C. / Conway, K. et al. | 2012
- A484
-
PRM134 Regression Methods for Health-Related Quality of Life Data in Longitudinal Settings: Are More Advanced Techniques Really Performing Better?Hunger, M. / Dö / ring, A. / Holle, R. et al. | 2012
- A485
-
PRM139 Including Patients in Multiple Groups and Multiple Times in the Same Group in Longitudinal Observational Research: A Cystic Fibrosis ExamplePasta, D. J. / Millar, S. J. et al. | 2012
- A486
-
PRM144 Cardiologists' Knowledge and Awareness of Guidelines for Medical Device Safety and Product Risk ManagementBozkurt, R. / Yildirim, J. et al. | 2012
- A487
-
PRM150 Latent Transition Analysis as a Tool for Analysing Clinical DataMayer, D. / Burgess, A. J. et al. | 2012
- A488
-
PRM155 A Pragmatic Randomized Clinical Trials – Design and Quality Assessment of the Source of Effectiveness DataKaczynski, L. / Solnica, B. et al. | 2012
- A489
-
PRM160 A New Value-Based Pricing Framework for the Optimal Pricing of Pharmaceutical AssetsHawryluk, E. A. / Malhotra, M. / Chawla, V. / Doyle, J. et al. | 2012
- A491
-
PRM171 Optimal Shopping: An Evauation of Decision Rules in Cost-Effectiveness Analysis (CEA)McKenna, C. / Claxton, K. et al. | 2012
- A492
-
PRM177 What is the Role of Early Health Technology Assessment of Biomarkers in the Pre-Clinical Development Phase? A Reflection on Lessons Learned With Multiple MyelomaGaultney, J. G. / Redekop, W. K. / Sonneveld, P. / Uyl-de Groot, C. A. et al. | 2012
- A493
-
PDB4 HbA1C Reduction Associated With Initial Versus Sequential Combination Therapy With Pioglitazone (PIO) and Dipeptidyl Peptidase-4 Inhibitors (DPP4i) in Patients With Type 2 Diabetes Mellitus (T2DM)Bron, M. / Chen, K. / Ayyagari, R. / Sharma, H. / Wu, E. Q. et al. | 2012
- A494
-
PDB9 Outcome of Fixed Dose Radioactive Iodine for the Treatment of HyperthyroidismObidiya, S. O. / Ogunjobi, K. / Eniojukan, J. F. et al. | 2012
- A495
-
PDB14 Characteristics of the Aboriginal People with Diabetes in the South-Western of Ontario, Canadareza Nakhai-Pour, H. / Tarride, J. E. / Blackhouse, G. / Xie, F. / O'Reilly, D. / Goeree, R. / Petrella, R. J. et al. | 2012
- A496
-
PDB19 A Systematic Review of Recent Data Describing the Risk of Complications in Type 1 Diabetes Mellitus PatientsPearson, I. / Wolowacz, S. / Irving, A. / Brockbank, J. / Chubb, B. / Gundgaard, J. / Briggs, A. / Davies, M. J. et al. | 2012
- A497
-
PDB25 Evaluation of Health Care Cost of Diabetes Before and After Counseling in South Indian Community SetupMateti, U. V. / Akari, S. / Adla, N. et al. | 2012
- A498
-
PDB30 The Pattern and Prescription Cost Among Diabetic Patients in the HO Municipal Hospital, Volta Region, GhanaOkotah, A. N. et al. | 2012
- A499
-
PDB35 Evaluation of the Long Term Economic Impact of Improving Hba1C in Type 2 Diabetes Patients in Saudi ArabiaTodorova, L. / Baabbad, R. / Smith-palmer, J. / Al-mansari, A. et al. | 2012
- A500
-
PDB41 Long-Term Evaluation of the Economic Impact of Reducing HbA1C by 1% in Type 2 Diabetes Patients in AlgeriaRoca, P. / Lamri, L. / Belhadj, M. / Pollock, R. F. / Valentine, W. J. / Todorova, L. et al. | 2012
- A501
-
PDB46 Anti-Diabetic Drugs and In-Patient Admissions Attributable to Diabetes in PortugalGouveia, M. / Laires, P. / Borges, M. / Augusto, M. / Martins, A. P. et al. | 2012
- A502
-
PDB51 Resource Utilization in the Management of Acromegaly: An Analysis From Southwest OntarioPetrella, R. J. / Van uum, S. / Hurry, M. et al. | 2012
- A503
-
PDB56 Development and Validation of Patient Reported Endpoints for T2DMBron, M. / Hudgens, S. / Stokes, J. / Banderas, B. / Viswanathan, P. / Dabbous, O. et al. | 2012
- A504
-
PDB61 Research on the Incidence and Cost of Hypoglycemia Episode in Patients With Type 2 Diabetes Mellitus (T2DM)Zheng, Y. / Wu, J. / sterle, A. et al. | 2012
- A506
-
PDB73 Obesity and Frequent Hypoglycemia in European Type 2 Diabetes PatientsVietri, J. / Isherwood, G. / Le pautremat, V. / Eschwè / ge, E. M. et al. | 2012
- A507
-
PDB78 Determinants of Treatment Changes of Oral Anti/Diabetic Drugs in the UKMaguire, A. / Mitchell, B. et al. | 2012
- A508
-
PSY4 Lenalidomide or Bortezomib for the Treatment of Relapsed/Refractory Multiple Myeloma (MM): A Comparative Effectiveness Analysis Using Indirect Statistical TechniquesKaura, S. / Dranitsaris, G. et al. | 2012
- A509
-
PSY10 An Indirect Comparison of Icatibant and Four Other Therapies for the Symptomatic Treatment of Acute Attacks of Hereditary Angioedema Types I and IIHelbert, M. / Pang, F. / Alvarez-Reyes, M. / Roskell, N. S. / Diwakar, L. et al. | 2012
- A510
-
PSY15 Impact of Chronic Immune-Mediated Inflammatory Diseases on Work Productivity: Literature ReviewGranados, D. / Depont, F. / Chevreul, K. et al. | 2012
- A511
-
PSY20 Cost-Effectiveness of Prophylaxis With an Anti-Inhibitor Complex Concentrate in Patients With Haemophilia and Inhibitors: Results From Pro-Feiba StudyGringeri, A. / Leissinger, C. / Cortesi, P. A. / Cristiani, M. / Fusco, F. / Mantovani, L. G. et al. | 2012
- A512
-
PSY25 Etanercept in Early Rheumatoid Arthritis: Economic Evaluation From the Public Payer Perspective in BrazilTakemoto, M. / Fernandes, R. A. / Fujii, R. K. / Mould, J. / Tang, B. et al. | 2012
- A514
-
PSY35 Assessment of the Most Bothersome Symptoms and Impacts Reported by Patients With Chronic Low Back PainRamasamy, A. / Blum, S. I. / Liedgens, H. / Martin, M. L. / McCarrier, K. P. / Quintanar-Solares, M. / Argoff, C. / Freynhagen, R. / Patrick, D. L. / Wallace, M. S. et al. | 2012
- A515
-
PSY40 Health-Related Quality of Life and Annual Direct Medical Cost of Patients With Haemophilia B in France: The EQOFIX StudyPolack, B. / Calvez, T. / Claeyssens, S. / Chambost, H. / Derlon, A. / Goudemand, J. / Rothschild, C. / Maurel, F. / Woronoff-Lemsi, M. C. et al. | 2012
- A516
-
PSY45 Social Economic Burden and Health-Related Quality of Life in Patients With Rare Diseases in Europe (BURQOL-RD Project). Spanish ResultsLinertová / R. / Ló / pez-Bastida, J. / Serrano-Aguilar, P. / Posada-de-la-Paz, M. et al. | 2012
- A517
-
PHS1 The Effect of Positioning and PNF-Exercise to Postoperative Bleeding After Hip ReplacementGombos, G. / Steinhausz, V. / Bajsz, V. / Sió / E. / Turcsanyi, K. / Molics, B. / Boncz, I. / Schmidt, B. et al. | 2012
- A519
-
PHS12 Meta-Analysis of Parkinson's Disease Risk With Hypertension, Serum Total Cholesterol, and Diabetes MellitusMounika, P. / Venkat, A. / Chaitanya, P. / Dev, K. et al. | 2012
- A520
-
PHS17 Costs of Influenza A(H1N1)2009 Infection During the Pandemic and the Postpandemic-Seasonal WavesGarin, O. / Galante, M. / Hollmann, M. / Sicuri, E. / Cots, F. / Garcia-Alté / s, A. / Ferrer, M. / Dominguez, x. / Castilla, J. et al. | 2012
- A521
-
PHS22 Burden of Invasive Pneumococcal Diseases in Older Adults in the New EU Countries of the Central EuropeTichopad, A. / Roberts, C. S. / Skoczynska, A. / Hryniewitz, W. / Gembula, I. / Hajek, P. / Krizova, P. / Motlova, J. / Avdicova, M. et al. | 2012
- A522
-
PHS28 The Cost of Management of Patients With Atrial Fibrillation : An Observational Study in UK NHS Primary CareKassianos, G. / Fuat, A. / Arden, C. D. / Hogan, S. / Baldock, L. et al. | 2012
- A523
-
PHS33 Cost Analysis of Dialysis Practice in TurkeyTatar, M. / Ergin oguzhan, G. / Kockaya, G. et al. | 2012
- A524
-
PHS39 Cost-Effectiveness of a Nurse-Led Integrated Chronic Care Approach Versus Usual Care in Patients With Atrial FibrillationHendriks, J. M. / Tomini, F. / Van asselt, A. D. et al. | 2012
- A525
-
PHS44 Economic Evaluation of Universal Hepatitis B Vaccination Strategy in JapanHirao, T. / Sato, T. / Sugimori, H. / Suka, M. / Yoda, T. / Yoshioka, A. / Akazawa, M. / Igarashi, A. / Kobayashi, M. / Ikeda, S. et al. | 2012
- A526
-
PHS49 Cost of Hypoglycaemia in Patients With Diabetes in PolandWidz, K. / Czech, M. / Hermanowski, T. et al. | 2012
- A527
-
PHS54 Use of Health Care Administrative Databases to Estimate the Health Care Burden of Bone or Bone Marrow Metastatic Deases in Breast Cancer Patients: A Population-Based StudyMantovani, L. G. / Scalone, L. / Furneri, G. / Ciampichini, R. / Cortesi, P. A. / Fornari, C. / Madotto, F. / Chiodini, V. / Cesana, G. et al. | 2012
- A528
-
PHS60 Health-Related Quality of Life in HIV/HCV Co-Infected Patients in IrelandMcgreal-bellone, A. / Cleary, S. / Farrell, G. / Bergin, C. / Barry, M. / Kieran, J. et al. | 2012
- A529
-
PHS65 Mapping the Disease-Specific FACT-P to the Preference-Based EQ-5D in Castration-Resistant Prostate CancerIvanescu, C. / Skaltsa, K. / Holmstrom, S. et al. | 2012
- A530
-
PHS70 Health Related Quality of Life As Predictor of Death Among Patients With Heart FailureEscobar, A. / Bilbao, A. / Gonzalez-Saenz de Tejada, M. / Fernandez-soto, M. / Lafuente, I. / Sanchez-haya, E. / Citores, L. et al. | 2012
- A531
-
PHS76 An Infuenza Vaccination Policy Based on a Previous Year's IllnessYamin, D. / Gavious, A. / Solnik, E. / Davidovitch, N. / Pliskin, J. S. et al. | 2012
- A532
-
PHS81 Health Care Organizations/Services Clustering: Comparison of Several Techniques Using UK DataMillier, A. / Mejri, S. / Aballea, S. / Toumi, M. et al. | 2012
- A533
-
PHS87 Cost of Diabetes in Insulin-Treated Patients in BulgariaDoneva, M. / Valov, V. / Borissova, A. M. / Tankova, T. / Savova, A. / Manova, M. / Petrova, G. / Czech, M. et al. | 2012
- A534
-
PHS93 HbA1c Test Utilization Among Hospitalized Patients With HyperglycemiaEby, E. / Gelwicks, S. / Marchlowska, P. A. et al. | 2012
- A535
-
PHS98 Clinical Characteristics, Treatment Patterns, and Resource Utilization in a Real-World European Population With DiverticulitisDavis, K. L. / Mitra, D. / Yen, L. et al. | 2012
- A536
-
PIH5 Preventable Drug-Related Hospital Visits and Admissions Associated with Laboratory or Physiologic Abnormalities - A Systematic-ReviewWilbur, K. / Hazi, H. / El-Badawi, A. et al. | 2012
- A538
-
PIH16 Epidemiology of Herpes Zoster and Its Related Resource Utilization: A Large Population-Based Study in IsraelWeitzman, D. / Shavit, O. / Stein, M. / Shay, N. / Cohen, R. / Chodick, G. / Shalev, V. et al. | 2012
- A539
-
PIH22 Clinical Efficacy and Cost-Effectiveness of Human Recombinant Interferon-α2B in Neonatal InfectionsSoldatova, I. / Pankratyeva, L. et al. | 2012
- A540
-
PIH27 Cost Analysis of Neonatal and Pediatric Parenteral Nutrition in BelgiumWalter, E. / Dragosits, A. / Noerens, K. / De Bosscher, H. / Blom, H. / Maton, P. et al. | 2012
- A541
-
PIH32 The Impact of Periods on Women's Quality of Life in Women Reporting a ProblemPumford, N. / Muston, D. / Wade, A. / Crawford, G. / Young, D. et al. | 2012
- A542
-
PIH37 Trends of Quality of Life in South Korean Adults During 2007-2010Chang, C. W. / Choi, I. S. / Lee, S. M. / Suh, D. C. et al. | 2012
- A543
-
PIH43 Comparison of Unintended Pregnancy Rates Among Women Who Initiated Oral Contraceptive Therapy with a 84/7 Estradiol or a 84/7 PlaceboBrewster, C. / Lage, M. J. / Grubb, E. et al. | 2012
- A544
-
PIH48 Service Uses and Costs of Child and Adolescent Psychiatric Patients Treated with Antipsychotics in TaiwanChang, H. C. / Mccrone, P. / Su, K. P. et al. | 2012
- A545
-
PND2 Effect of Cognitive Behavioural Therapy in Multiple Sclerosis Fatigue: A Systematic Review of Randomised Controlled TrialsKohli, I. S. / Kataria, A. / Singla, S. / Kaushik, P. / Jindal, R. / Aggarwal, A. et al. | 2012
- A546
-
PND7 Off-Label Use of Antiepileptic Drugs and its Costs – a Drug Utilization Study in PortugalAfonso-Silva, M. / Oliveira-Martins, S. / Cabrita, J. et al. | 2012
- A547
-
PND13 Budget Impact Analysis and Update of a Cost Effectiveness Evaluation for Alpha (α) Polymorph Rifaximin for the Treatment of Acute Hepatic EncephalopathyCardona, D. P. / Zapata, L. / Ceballos, M. / Diez, F. / Rico, I. / Zavala, A. et al. | 2012
- A548
-
PND18 Impact of Co-Morbidities on the Economic Burden of Parkinson'S Disease in Germany Post-2000Takyar, S. / Kataria, A. / Rajput, A. / Kaur, M. et al. | 2012
- A550
-
PND29 Cost Evaluation of Multiple Sclerosis at Different Stages in IranKhanizadeh, H. et al. | 2012
- A552
-
PND40 Cost-Utility Analysis of Fingolimod in Brazilian Patients With Multiple SclerosisSilva, N. L. / Takemoto, M. L. / Cruz, R. B. / Suzuki, C. et al. | 2012
- A553
-
PND45 Differential Outcomes in Patients With Alzheimer'S Disease (AD) Treated With Donepezil 23Copher, R. / Li, X. / Powers, A. / Clionsky, E. et al. | 2012
- A554
-
PND50 Estimation of the Effect of Dalfampridine Extended Release on Health Utility in Patients With Multiple Sclerosis Using Two Equations for Mapping the MSWS-12 to the EQ-5DLimone, B. / Sidovar, M. / Gaebler, J. A. / Lee, S. / Coleman, C. I. et al. | 2012
- A556
-
PND60 Non-Diabetic Peripheral Neuropathic Pain is Underdiagnosed in GP Practices Although it has High Impact on Patients' Health Related Quality of LifeBrodszky, V. / Komoly, S. / Bereczki, D. / Embey-Isztin, D. / Gulá / csi, L. / Balogh, O. / V. Hevé / r, N. / Torzsa, P. et al. | 2012
- A557
-
PND66 Therapeutic Equivalence as a Means of Improving the Efficiency in the Treatment of Multiple SclerosisBautista Paloma, F. J. / Flores Moreno, S. / Ucles Sanchez, A. / Casado Chocan, J. / Jimenez Hernandez, D. et al. | 2012
- A558
-
PND71 Predictors of Treatment Class Choice in Parkinson's DiseaseGrubb, E. / Castelli-Haley, J. / Treglia, M. / Lage, M. J. et al. | 2012
- A559
-
PRS2 A Retrospective Epidemiologic Review of COPD in KoreaJoo, H. / Jung, K. S. / Jeung, J. et al. | 2012
- A560
-
PRS8 Burden of Exacerbations in Patients With COPD in the Netherlands: a Real-Life StudyOverbeek, J. A. / Balp, M. M. / Penning, F. J. / Dekhuijzen, P. N. / Herings, R. M. et al. | 2012
- A561
-
PRS14 Clinical and Pharmacoeconomic Aspects of Allergen Immunotherapy in the Slovak RepublicBielik, J. / Pruzinec, P. / Tor, P. et al. | 2012
- A562
-
PRS20 Cost-Benefit Analysis for a Treatment of Pulmonary Arterial HypertensionIskedjian, M. / Walker, J. H. / McLean, A. / Farah, B. / Berbari, J. / Watson, J. A. et al. | 2012
- A563
-
PRS25 Cost Analysis of Omalizumab Use in Patients With Severe Uncontrolled Asthma Within the Mexican Public Health Care SystemLemus-Carmona, E. / Reyes-Lopez, A. / Jimenez Aranda, P. et al. | 2012
- A564
-
PRS30 Cost-Effectiveness Analysis of 100% Whey-Based Partially Hydrolyzed Infant Formula Used for Prevention of Atopic Dermatitis in GermanyErdogan Ciftci, E. / Horodniceanu, E. G. / Botteman, M. F. / Detzel, P. / Verheggen, B. G. et al. | 2012
- A565
-
PRS35 The Economic Burden of HAE: Findings From the HAE Burden of Illness Study in Europe (HAE-BOIS-Europe)Aygö / ren-Pü / rsü / n, E. / Bygum, A. / Caballero, T. / Beusterien, K. / Hautamaki, E. / Musingarimi, P. / Wait, S. et al. | 2012
- A566
-
PRS41 Characteristics and Determinants of Palivizumab Use in the NetherlandsHouweling, L. M. / Penning-van Beest, F. J. / Bezemer, I. D. / van Lingen, R. A. / Herings, R. M. et al. | 2012
- A567
-
PRS46 Health Care Resource Use of Patients With Cystic Fibrosis (CF) in the UKLambrelli, D. / Wasiak, R. / Ingram, A. / Harrow, B. / Becker, C. / Eriksson, D. / Wyatt, H. et al. | 2012
- A569
-
PSS10 Economical Burden of Severe Visual Impairment and Blindness – a Systematic ReviewKö / berlein, J. / Beifus, K. / Finger, R. et al. | 2012
- A570
-
PSS15 A New Insight Into Cost-Effectiveness Analyses in Atopic Dermatitis: The Tacrolimus 0.1% Ointment Versus Ciclosporin ComparisonAlmeida, J. / Vandewalle, B. / Silva, M. J. / Fé / lix, J. et al. | 2012
- A571
-
PSS20 Cost-Utility Analysis of Treatments for Macular Edema Secondary to Retinal Vein OcclusionDuff, S. / Gricar, J. / Kymes, S. / Tran, I. / Turpcu, A. / Sternberg, G. et al. | 2012
- A572
-
PSS25 Validation of the Patient Benefit Index (PBI) for the Assessment of Patient-Defined Benefit in the Treatment of PsoriasisFeuerhahn, J. / Blome, C. / Radtke, M. A. / Augustin, M. et al. | 2012
- A576
-
ISPOR 15th Annual European Congress Disclosure Information for Research Presentations| 2012
- A587
-
ISPOR 15th Annual European Congress Research Abstracts Author Index| 2012
- A602
-
CN1 Statins and the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Virus InfectionTsan, Y. / Lee, C. / Wang, J. / Chen, P. et al. | 2012
- A603
-
DB2 Vitamin D Deficiency and Diabetes: Perceptions of Pharmacists and PhysiciansJalundhwala, F. / Majumdar, A. / Malthankar, S. / Jalundhwala, Y. et al. | 2012
- A604
-
HC3 The Process of Updating the Items of National Health Insurance Benefits Schedule in Taiwan: is It Fair and Legitimate?Lin, C. W. et al. | 2012
- A605
-
ME4 Using Discrete Choice Experiments to Value Health States for Economic Evaluation – the SF-6D in AustraliaNorman, R. / Viney, R. / Brazier, J. / Burgess, L. / Cronin, P. / King, M. / Ratcliffe, J. / Street, D. J. et al. | 2012
- A607
-
EX3 A Evaluation of the Effects from China Drug Policy Reform During 2009-2011: Some Success, Many Unintended EffectsGuan, Q. / Cai, J. / Dummett, H. / Tan, S. C. et al. | 2012
- A608
-
PR1 Does Medication Adherence Correlate With Health-Related Quality of Life? Findings From a Descriptive AnalysisSaleem, F. / Hassali, M. A. / Shafie, A. A. / Aljadhey, H. / Haq, N. / Atif, M. et al. | 2012
- A610
-
PHP8 Factors Associated with Unnecessary Use of Antibiotics in U.S. State Medicaid ProgramsLi, P. / Marcus, S. / Metlay, J. / Doshi, J. A. et al. | 2012
- A611
-
PHP14 The Implementation of Essential Medicine Policy in China: Pros and ConsHu, S. / Zhang, Y. / He, J. J. et al. | 2012
- A613
-
PHP25 Market Analysis of Antibiotics Consumption in Northern Part of Iran During 2001-2010Zaboli, P. / Ala, S. / Kebriaee Zadeh, A. / Abdollahiasl, A. / Nikfar, S. et al. | 2012
- A614
-
PHP30 The Utilization and Expenditure of Reimbursed Digestive Enzyme Agents in TaiwanYang, W. W. / Wang, Y. C. / Pwu, R. F. et al. | 2012
- A615
-
PHP36 Comparing Oral 5-Aminosalicylic Acid Treatment Persistence and Adherence in Patients with Ulcerative Colitis in the United StatesYen, L. / Wu, J. / Hodgkins, P. / Nichol, M. B. et al. | 2012
- A616
-
PHP41 Risk Management in Iranian Pharmaceutical Companies to Ensure Accessibility and Quality of MedicinesJaberidoost, M. / Abdollahiasl, A. / Farshchi, A. / Dinarvand, R. et al. | 2012
- A617
-
PHP47 Impact of Economic and Policy Factors on China'S Health Care ExpenditureZhang, J. / Ando, G. / Bharath, A. et al. | 2012
- A618
-
PHP53 Comparative Evaluation of Drug Information Sources Used by DoctorsKini, S. / Ankush, C. / Pratik, G. / Shahank, W. / Ligade, V. S. / Sreedhar, D. / Udupa, N. et al. | 2012
- A619
-
PHP60 Iranian Pharmacists' Job Satisfaction: Analysis Through Various Job CharacteristicsForoughi Moghadam, M. J. / Peiravian, F. / Naderi, A. / Mehralian, G. / Rasekh, H. et al. | 2012
- A621
-
PHP76 Evidence Requirements for Pricing and Reimbursement Decision Making for Orphan Drugs in AsiaTan, S. / Dummett, H. / Kirpekar, S. / Guan, Q. / Priest, V. L. et al. | 2012
- A622
-
PHP81 Factors Influencing Interprofessional Collaboration: A Literature Review from 2004-2011Chang, E. H. / Doucette, W. R. et al. | 2012
- A623
-
PHP87 Satisfaction Assessment of Insurance System for Urban Residents (URMS) of University Students in ShenyangZhang, F. / Li, S. C. / Du, J. et al. | 2012
- A625
-
PHP99 Implementation of a Formulary Management Programme in SingaporeZhao, Y. J. / Teng, M. / Khoo, A. L. / Lim, B. P. et al. | 2012
- A626
-
PHP108 Pattern of Antibiotics Usage in Malaysian Hajj PilgrimAbd Aziz, N. / Hassan, Y. / Hashim, H. / Malik Mansoor, S. / Abd Shatar, A. K. et al. | 2012
- A627
-
PHP113 Utilization of FPG, HbA1C and Self-Monitoring of Blood Glucose (SMBG) in Community Health Centers in the Shanghai AreaMast, O. / Tan, A. et al. | 2012
- A628
-
PHP118 The Attitude of Farmers to the New Rural Cooperative Medical Scheme in the Northwest of China: A Cross-Sectional StudyXu, C. / Gericke, C. A. et al. | 2012
- A629
-
PCV5 The Effeects of Statins on Blood Presure in Normotensive or Hypertensive Subjects-a Meta-Analysis of 18 Randomized Controlled Trials Involving 5628 ParticipantsBanach, M. / Nikfar, S. / Rahimi, R. / Mikhailidis, D. P. / Narkiewicz, K. / Rysz, J. / Abdollahi, M. et al. | 2012
- A630
-
PCV11 Use of Anti-Infectives for Systemic Administration in Serbia in 2010Milijasevic, B. / Tomic, Z. / Sabo, A. / Vukmirovic, S. et al. | 2012
- A631
-
PCV19 Hospitalization Costs and Their Predictors in Patients With Venous Thromboembolism in ChinaWu, J. / Yang, L. / Zhu, G. et al. | 2012
- A632
-
PCV26 Lifetime Cost-Effectiveness Analysis of Ticagrelor in Patients With Acute Coronary Syndromes Based on the Plato Trial: A Singapore Health Care PerspectiveChin, C. T. / Mellströ / m, C. / Chua, T. S. / Matchar, D. B. et al. | 2012
- A633
-
PCV31 Cost-Effectiveness of Apixaban Versus Enoxaparin for the Prevention of Postsurgical Venous Thromboembolism in KoreaOh, J. J. / Shin, H. H. / Jung, H. / Park, J. H. / Ko, S. K. et al. | 2012
- A634
-
PCV36 Validation 36 and Comparison of the SF-6D and EQ-5D in Chinese Patients With Stable Angina PectorisWu, J. / Han, Y. / Gao, Y. / Zhou, J. / Chen, Z. / Sun, H. et al. | 2012
- A635
-
PGI5 Increasing Demands for Medical and Drug Utilization in Patients With Long-Term Irritable Bowel Syndrome in TaiwanHsu, C. C. / Chen, L. C. / Wen, Y. H. et al. | 2012
- A636
-
PGI10 Factors Associated With Treatment Adherence and Persistence in Canadian Patients With Ulcerative Colitis (Uc): Analysis of Prescription Claims From the Ramq DatabaseLachaine, J. / Yen, L. / Beauchemin, C. / Hodgkins, P. et al. | 2012
- A637
-
PGI16 Treatment With Prucalopride for Chronic Constipation Improves the Symptoms and Quality of Life of Patients in ChinaKe, M. Y. / Zou, D. W. / Yuan, Y. Z. / Li, Y. Q. / Lin, L. / Ji, J. / Song, W. J. / Du, X. X. / Chang, J. H. et al. | 2012
- A638
-
PIH6 Cost-Effectiveness of Rotavirus Immunization in Vietnam: Exploring Impacts of Herd Immunity and Patterns of BreastfeedingofTu, H. A. / Coyte, P. / Li, S. C. / Postma, M. J. et al. | 2012
- A639
-
PIH12 A Descriptive Study of Health Related Quality of Life among General Population of Quetta, PakistanUl Haq, N. / Hassali, M. A. / Shafie, A. A. / Saleem, F. / Aljadhey, H. / Atif, M. / Iqbal, Q. et al. | 2012
- A640
-
PRS6 Self-Reported Adherence to Inhaled Corticosteroids and Beliefs About Medicines in Asthma Patients: A Study From Emergency Room of a Chest Hospital in Delhi, IndiaKotwani, A. / Shendge, S. et al. | 2012
- A641
-
PRS11 Assessment of Knowledge About Tuberculosis Among Libyan and Non Libyan Populations in North East LibyaSolliman, M. M. / Hassali, M. A. / Al-Haddad, M. S. / Atif, M. / Shafie, A. A. / Saleem, F. / Aljadhey, H. / Haq, N. et al. | 2012
- A642
-
PSS3 Medical Resource Use and Associated Costs in Open-Angle Glaucoma in 10 Asia-Pacific CountriesGerlier, L. / Lamotte, M. / Caputo, J. / Tan, R. et al. | 2012
- A643
-
PSS8 Health Burden of Vision Problems in Asia: A Study of Malays and Indians in SingaporeWang, X. / Ang, M. / Chiang, P. / Zheng, Y. / Cheng, C. Y. / Lamoureux, E. / Wong, T. Y. / Luo, N. et al. | 2012
- A644
-
PUK5 Clinical and Economic Impacts of Clinical Pharmacy Education on Infection Management Among Patents With Chronic Kidney Disease in a Hospital (Indonesia)Nasution, A. / Syed Sulaiman, S. A. / Shafie, A. A. et al. | 2012
- A645
-
PRM4 QALY and Productivity Loss: Empirical Evidence for “Double Counting”Shiroiwa, T. / Fukuda, T. / Shimozuma, K. / Ikeda, S. et al. | 2012
- A646
-
PRM11 Evidence for Validity of a National Patient-Reported Survey in Japan: The Japan National Health and Wellness SurveyDibonaventura, M. D. / Fukuda, T. / Stankus, A. et al. | 2012
- A647
-
PRM16 Evaluation of Personalized Breast Cancer Test-Treatment Strategies - A Cross-Validation Study Between a Discrete-Event Simulation and a Markov ModelJahn, B. / Rochau, U. / Arvandi, M. / Kuehne, F. / Kluibenschaedl, M. / Paulden, M. / Krahn, M. / Siebert, U. et al. | 2012
- A648
-
PRM21 Validity and Reliability of the 8-Item Morisky Medication Adherence Scale in Patients Taking Warfarin in SingaporeWang, Y. / Kong, M. C. / Ko, Y. et al. | 2012
- A650
-
PRM32 Reliability and Validity of an Instrument Used in a Tobacco Cessation Intervention Study Among Patients With DiabetesIbrahim, K. A. / Syed sulaiman, S. A. / Shafie, A. A. / Awaisu, A. / Lajis, R. / Nasution, A. et al. | 2012
- A652
-
PRM44 Clinical and Comparative Economic Value - A Novel Pharmacoeconomic Analysis Embedded in the Drug Development ProcessFang, X. / Seo, M. / Standing, M. / Xu, Z. / Jacobson, S. / Woolmore, A. et al. | 2012
- A653
-
PCN5 Impact of Erythropoiesis Stimulating Agents on Survival among Patinets With Colorectal Cancer Receiving ChemotherapySato, M. / Freedman, A. / Trovato, J. / Zhan, M. / Cunningham, F. / Weiss Smith, S. et al. | 2012
- A654
-
PCN10 Risk of Breast Cancer and Statins: A Population-Based Nested Case-Control Study in Chinese PopulationChan, A. L. / Leung, H. W. / Wang, J. J. et al. | 2012
- A655
-
PCN16 Comparison of the Efficacy and Cost of Novel Targeted Cancer TherapiesKaura, S. / Khan, Z. et al. | 2012
- A656
-
PCN22 Cost-Effectiveness Analysis of Cervical Cancer Screening With Self-Sampling for Human Papillomavirus (HPV) Testing in TaiwanTsai, B. C. / Chow, I. H. / Liao, C. H. / You, S. L. / Tang, C. H. / Pwu, R. F. et al. | 2012
- A657
-
PCN27 Disclosing Complementary and Alternative Medicines (CAM) Use to the Health Care Providers:A Descriptive StudyFarooqui, M. / Hassali, M. A. / Knight, A. / Akmal, A. / Farooqui, M. A. / Seang, T. B. et al. | 2012
- A659
-
PDB5 Statin is a Reasonable Treatment Option for Patients With Polysystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled TrialsGao, L. / Li, S. C. et al. | 2012
- A660
-
PDB12 Role of Chromium in Type-2 Diabetes Therapy: A Systematic Review StudyFarshchi, A. / Seyedifar, M. / Abdollahiasl, A. / Nikfar, S. / Jaberidoost, M. / Esteghamati, A. / Abdollahi, M. et al. | 2012
- A661
-
PDB17 Comparison of Clinical and Economic Outcomes Associated With Dpp4 Inhibitors (DPP4I) Versus Sulfonylurea (SU) in Combination with Metformin (MET) or Pioglitazone (PIO) for the Treatment of Type 2 Diabetes Mellitus (T2DM)Bron, M. / Chen, K. / Cheng, D. / Bensimon, A. G. / Wu, E. Q. et al. | 2012
- A662
-
PDB22 The Direct Medical Cost for Diabetes Mellitus (DM) Related Complications in ChinaZheng, Y. / sterle, A. / Liu, X. / Wu, J. et al. | 2012
- A664
-
PDB33 Physician'S and Patient'S Perceptions and Beliefs Regarding Insulin Initiation and Use in Patients With Type 2 Diabetes (T2DM) in ChinaLiu, L. L. / Babineaux, S. M. / Kadziola, Z. / Brnabic, A. J. / Luo, T. et al. | 2012
- A665
-
PIN2 Assessing the Diagnostic Performance of Human Immunodeficiency Virus Type 1 (HIV-1) Tropism Testing Methods: A Systematic Review of Genotypic Sequencing of the Third Hypervariable (V3) Loop and Enhanced-Sensitivity Phenotypic Assay TechnologyNeedham, M. O. / Paech, D. / Norris, S. / Campbell, S. et al. | 2012
- A666
-
PIN7 Estimate of Infectious Disease Burden Attributable to Climate ChangePathak, P. / Rana, C. et al. | 2012
- A667
-
PIN13 Cost of Antibiotics Used for Nosocromaial Infection Treatment in Inpatient Department at Nakhon Pathom HospitalTewthanom, K. et al. | 2012
- A669
-
PMH6 Factors Associated with Medical Expenditure for Dementia in South KoreaJang, S. / Lee, T. J. / Yu, S. Y. et al. | 2012
- A670
-
PMH12 Medication Adherence, Diabetic Care and Risk of Acute Complications of Type II Diabetics with Schizophrenia Receiving Oral Hypoglycemic TherapyCheng, J. S. / Shih, Y. T. et al. | 2012
- A671
-
PMS5 A Randomized, Placebo Controlled Trial to Compare Safety and Efficacy Between Curcuma Longa Linn Extract [NR-INF-02], Glucosamine Sulphate and Combination of Two in the Treatment of Painful Knee OsteoarthritisKulkarni, C. / Madhu, K. / Saji, M. et al. | 2012
- A672
-
PMS12 Cost Implication of Prescriptions in Private and Public Health Institutions in Bayelsa State of NigeriaEniojukan, J. F. / Orumwense, D. O. / Obidiya, S. O. et al. | 2012
- A673
-
PMS17 Burden of Ankylosing Spondylitis in Urban ChinaTang, B. / Yang, L. / Liu, Y. / Chapnick, J. / Dong, P. / Wu, M. / He, S. et al. | 2012
- A674
-
PMS22 Improvement on Quality of Life and Daily Function in Rheumatoid Arthritis Patients Treated with Infliximab in ChinaHe, D. Y. / Chen, J. W. / Bi, L. Q. / Wu, L. J. / Lin, J. / Wang, N. S. / Li, J. G. / Yue, N. / Feng, W. W. et al. | 2012
- A675
-
PND5 Budget Impact of Oral Prolonged-Release Fampridine for Management of Walking Disability Associated With Multiple Sclerosis in TaiwanLee-Grossman, C. W. / Alexopoulos, S. T. / Murphy, D. R. et al. | 2012
- A676
-
PND11 Lacosamide for the Treatment of Partial Onset Seizures With or Without Secondary Generalisation: Cost-Effectiveness Analysis on Treating Patients With Lacosamide in Combination With a Non-Sodium Anti-Epileptic MedicationMakarounas-Kichmann, K. / Kirchmann, M. / Monin, N. et al. | 2012
- A677
-
PSY1 Burdens of Psoriasis in the Asia Pacific Region: A Literature ReviewSchenkel, B. / Leartsakulpanitch, J. / Yue, N. et al. | 2012
- A678
-
PSY7 Impact of Anti-Viral Treatment on the Economic Burden of Chronic Hepatitis B in TaiwanChen, P. J. / Chen, C. J. / Yang, H. I. / McLeod, E. / Heatley, R. et al. | 2012
- A679
-
PSY13 Systematic Review of the Economic and Epidemiological Burden of Bleeding-Related Complications in Hong KongTan, J. / Standfield, L. / Metz, L. et al. | 2012
- A680
-
PSY19 Access to Care and Health Outcomes Among the Hemophilia A Population in Developing Countries: A Comparison Between Philippines and ColombiaZhang, M. / Ito, D. / Xiong, Y. / Epstein, J. et al. | 2012
- A682
-
ISPOR 5th Asia-Pacific Conference Disclosure Information for Research Presentations| 2012
- A685
-
ISPOR 5TH Asia-Pacific Conference Research Abstracts Author Index| 2012
- i
-
Table of Contents| 2012
- III
-
Instructions for Authors| 2012
-
NI3 Patient Access Schemes in the New NHSSpoors, J. / Brown, C. / Johnson, N. / Rietveld, A. et al. | 2012
-
QL2 Evaluation of Minimal Clinically Important Differences for Health-Related Quality of Life Scales in Parkinson'S DiseaseWinter, Y. / Lubbe, D. / Oertel, W. / Dodel, R. et al. | 2012
-
RU2 Potential Time Savings With Trastuzumab Subcutaneous (SC) Injection Versus Trastuzumab Intravenous (IV) Infusion: Results from Interviews Conducted As Part of a Time-and-Motion Study (T&M) Across 17 SitesDe Cock, E. / Tao, S. / Urspruch, A. / Knoop, A. et al. | 2012
-
MO3 Lessons Learned From a Cross-Validation Between a Discrete-Event Simulation Model and a Markov Model for Personalized Breast Cancer TreatmentJahn, B. / Rochau, U. / Arvandi, M. / Kurzthaler, C. / Saverno, K. R. / Fü / hne, F. / Kluibenschaedl, M. / Krahn, M. / Paulden, M. et al. | 2012
-
DU4 Inappropriate Use of Drugs Influences Health Budget of PopulationSabo, A. / Tomic, Z. / Calasan, J. / Milijasevic, B. / Vukmirovic, S. et al. | 2012
-
PHP4 Financial Penalties for Improving Drug AdherenceRottenkolber, D. et al. | 2012
-
PRM140 An Applied Comparison of Meta-Analysis Techniques Using Bacille Calmette Guerin Vaccine StudiesLewis-Beck, C. / Baser, E. / Baser, O. et al. | 2012
-
PRM149 A Random Utlity Model Using a Transaction Cost Politics Approach to Adjust Health Systems to Economic TransitionHuttin Christine, C. et al. | 2012
-
PRM170 Optimizing Public Health Decision Over Time: A Dynamic Budget Optimization Model With Multiple Criteria Decision MakingEthgen, O. / Topachevskyi, O. / Connolly, M. / Standaert, B. et al. | 2012
-
PDB2 Systematic Literature Review of the Efficacy and Safety of Metformin Extended Release Relative to Metformin Immediate Release in the Treatment of Type 2 Diabetes MellitusAranda-reneo, I. / Villoro, R. / Hidalgo, A. / Donato, B. M. / Juarez-garcia, A. et al. | 2012
-
PDB8 Weight Loss of ≥3% of Body Weight After Initiating New Anti-Diabetic Therapy is Associated With Glycemic Control at 6 Months in Patients With Type 2 DiabetesMcadam-marx, C. / Bellows, B. K. / Wygant, G. D. / Mukherjee, J. / Unni, S. / Ye, X. / Iloeje, U. H. / Brixner, D. et al. | 2012
-
PDB21 Chart Audit and Budget Impact Analysis of Pasireotide Versus Second-Line Therapies in the Treatment of Cushing's Disease in GermanyBadia, X. / Forsythe, A. / Stemmer, V. / Cummins, G. et al. | 2012
-
PDB42 Evaluating the Clinical and Cost Outcomes Associated With Improving Glycemic Control in Type 2 Diabetes Patients in IndiaTodorova, L. / Shah, S. N. / Valentine, W. J. et al. | 2012
-
PDB47 Effects of Patient-Reported Non-Severe Hypoglycaemia on Health Care Resource Use and Work-Time Loss in Seven European CountriesGeelhoed-duijvestijn, P. H. / Pedersen-bjergaard, U. / Jensen, M. M. / stenson, C. G. et al. | 2012
-
PDB76 Clinical Effectiveness of Increased Physical Activity in Type 2 Diabetes, Systematic ReviewHerrmann, K. H. / Semlitsch, T. / Jeitler, K. / Schuermann, C. / Janzen, T. / Hemkens, L. G. / Matyas, E. / Pignitter, N. / Siebenhofer-kroitzsch, A. / Horvath, K. et al. | 2012
-
PSY3 Disease Activity Indices (DAIS) in Systemic Lupus Erythematosus (SLE)Wyrwich, K. / Winnette, R. / Oglesby, A. / Narayanan, S. et al. | 2012
-
PSY26 Cost-Effectiveness of Hematopoietic Stem Cell Mobilization Strategies in Multiple Myeloma and Lymphoma Patients in Czech RepublicVitova, V. / Tichopad, A. / Sturdikova, M. / Kucera, Z. / Lysak, D. / Koristek, Z. et al. | 2012
-
PHS3 Assessing the Survival Rates and Economic Burden of Prostate Cancer in the United States Veteran PopulationBaser, O. / Xie, L. / Huang, A. / Li, L. / Fritschel, E. K. / Wang, L. et al. | 2012
-
PHS6 Diagnosis Rates for Alzheimer's Disease in Taiwan in 2005 by Age Using National Health Insurance Claims DataHung, Y. N. / Kadziola, Z. / Fuh, J. L. / Hwang, J. P. / Lin, C. / Brnabic, A. / Belger, M. A. / Montgomery, W. et al. | 2012
-
PHS10 HbA1c Testing Frequency in Primary Care Diabetes Patients in Germany and in the UKKostev, K. / Grunow, S. / Rockel, T. et al. | 2012
-
PHS18 Economic Burden of Atopic Dermatitis from a United States Payer PerspectiveJoish, V. N. / Sullivan, S. D. / Hartisch, C. / Kamalakar, R. / Eichenfield, L. F. et al. | 2012
-
PHS21 Out-of-Pocket Financial Burden in Atrial Fibrillation and Potential Impact on Care: Comparison Across Five European Countries Using the European Patient Survey in Atrial Fibrillation (EUPS-AF)Mittendorf, T. / Zamorano, J. L. / Bakhai, A. / Berto, P. / Leach, N. / Sandberg, A. / Oberdiek, A. / Greiner, W. et al. | 2012
-
PHS30 Health Care Costs in Psoriatic Arthritis (PSA) Patients Newly Initiated on a Biologic Disease-Modifying Anti-Rheumatic Drug (DMARDS) or Methotrexate (MTX)Zhang, F. / Hiscock, R. / Curtis, J. et al. | 2012
-
PHS58 Change in Health-Related Quality of Life After Occpational Therapy in Community-Dwelling Dependent Elderly: A Randomised Controled TrialNoto, S. / Uemura, T. / Moriwaki, K. et al. | 2012
-
PHS84 Analyzing Pharmaceutical Expenditure in Greece:Unwinding Ariadne's ClueSiskou, O. / Kaitelidou, D. / Schneider, M. / Kalogeropoulou, M. / Tsavalias, K. / Passaloglou, S. / Kouli, E. / Galanis, P. / Kontozamanis, V. / Liaropoulos, L. et al. | 2012
-
PHS88 Pharmacist House Calls in Home Care in JapanImai, H. / Nakao, H. / Nanami, Y. / Onda, M. et al. | 2012
-
PHS89 How Can We Measure the Impact of Clinical Pharmacy Interventions? A Retrospective Drug Cost AnalysisClaus, B. / Robays, H. / Annemans, L. et al. | 2012
-
PIH12 Burden of Early-Onset Neonatal Sepsis in the Russian FederationSoldatova, I. / Pankratyeva, L. / Avxentyeva, M. / Omelyanovsky, V. et al. | 2012
-
PIH29 Identification of Factors and Their Influence on Patient Adherence to Intravenous Medication for Chronic Conditions: Findings of a Literature Review in Osteoporosis and Crohn's DiseaseWilliams, A. E. / Oldman, A. H. et al. | 2012
-
PIH39 Occupational Stress and Burnout: Impact on the Attitudes of Pharmacists in Providing Pharmaceutical ServicesJocic, D. / Krajnovic, D. / Lakic, D. / Tasic, L. et al. | 2012
-
PIH36 Quality of Life of Medical University of Warsaw Faculty of Pharmacy Students in 2010-2012Zawodnik, S. / Krancberg, A. N. / Hermanowski, T. R. et al. | 2012
-
PND21 Multiple Sclerosis in Russian Federation: Evaluation of Social and Economical Burden in Real Clinical PracticeYagudina, R. / Kulikov, A. / Litvinenko, M. et al. | 2012
-
PND54 Fatigue and Quality-of-Life in Multiple Sclerosis Patients With Spasticity in Germany - Results of the Move 1 StudyPfiffner, C. / Henze, T. / Zettl, U. / Essner, U. / Flachenecker, P. et al. | 2012
-
PND73 Multiple Sclerosis in Germany: Outpatient Health Care PatternsHö / er, A. / Schiffhorst, G. / Fischaleck, J. / Gehrmann, L. / Ahrens, H. / Carl, G. / Sigel, K. O. / Osowski, U. / Bleβ et al. | 2012
-
PSS16 Cost-Effectiveness of Tacrolimus Ointment in Children With Moderate and Severe Atopic Dermatitis: Twice-Daily Maintenance Treatment Versus Standard Twice-Daily Reactive Treatment of Exacerbations From the Perspective of the Spanish National Health ServiceMunro, V. / Hart, W. M. et al. | 2012
-
PSS23 Patient Burden Associated With Lack of Treatment Satisfaction Amongst Psoriasis Patients Receiving Traditional Systemic TherapiesO'Hara, J. / Lobosco, S. / Thompson, G. / Piercy, J. et al. | 2012
-
PSS33 Treatment Patterns of Biologic Use in Psoriasis Patients in EnglandKhalid, J. M. / Fox, K. M. / Globe, G. / Maguire, A. / Chau, D. et al. | 2012
-
PSS34 Impact of Specialty on Patient-Physician Interaction and Treatment Patterns: An on-Line Study of Eczema PatientsCascade, E. / Burgess, A. J. / Gee, B. / Downing, J. / Nixon, M. et al. | 2012
-
CE2 Cost-Effectiveness of the Real-World Use of Nucleic Acid Test Screening to Donated Blood for Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus: Experience From Taiwan, a Country With a High Prevalence of Hepatitis B and C InfectionsWu, G. H. / Wang, Y. C. / Lin, S. J. / Lin, K. S. et al. | 2012
-
DB1 Epidemiology, Treatment and Economic Burden of Type 2 Diabetes Mellitus With Nephropathy Complications in ChinaHuang, Y. Y. / Fan, W. J. / Zhu, J. J. / Zhan, L. / Chen, W. et al. | 2012
-
CL3 Anticoagulation Control of a Pharmacist Managed Anticoagulation Clinic in a National Referral Centre in MalaysiaThanimalai, S. / Shafie, A. A. / Ahmad Hassali, M. A. / Sinnadurai, J. et al. | 2012
-
HT2 Cost-Effectiveness Analysis of Bone Mineral Density Screening ToolsKang, E. / Lee, B. K. et al. | 2012
-
PHP6 The Study of Antihyperglycemic Drug Use Patterns and the Toward Clinical Excellence Network'S Diabetes (TCEN DM) Indicators in Patients with Type 2 Diabetes Mellitus at Samutsakhon HospitalPongmesa, T. / Luckanajantachote, P. / Piensaknusorn, N. / Tangjittanawat, B. / Kanjanawiwin, A. / Charoenworachai, N. / Saelim, W. et al. | 2012
-
PHP7 Health Care Decision Making in Mainland China, Korea, and Taiwan: The Road Ahead?Mitchell, B. / Curtis, B. / Liu, L. L. / Boye, K. S. / Papadimitropoulos, M. et al. | 2012
-
PHP33 Drug-Related Problems and Length of Stay in the Management of Infection in Patients with Chronic Kidney DiseaseNasution, A. / Syed Sulaiman, S. A. / Shafie, A. A. et al. | 2012
-
PHP44 Implementation & Evaluation of Essential Medicines List 2011 in a Rural Resource Limited District Hospital in IndiaThomas, D. / Seetharam, G. / Alvarez-Uria, G. et al. | 2012
-
PHP51 Managements of Febrile Neutropenia Among Non-Hodgkin's Lymphoma Patients in TaiwanLin, W. T. / Hsiao, F. Y. / Chiang, S. C. / Wen, Y. W. et al. | 2012
-
PHP64 Analyzing the Annual Adverse Drug Reactions at a Regional Teaching Hospital of Southern TaiwanLin, P. T. / Ta, C. L. et al. | 2012
-
PCV2 Evaluation of Stroke Risk Associated With Antipsychotic Use in Patinets with Cardiovascular DiseasesWang, M. T. / Lee, M. F. / Lo, Y. W. et al. | 2012
-
PCV16 Associations Between Patient Demographics, Pharmacotherapy Use, and Cost, Resource Utilization, and Quality-of-Life Burden in Adult Cardiac Arrhythmia PatientsTang, D. H. / Gilligan, A. et al. | 2012
-
PCV21 Hospital Based Cost Survey of Acute Coronary Syndrome in South KoreaKim, B. R. et al. | 2012
-
PCV22 Pharmacist'S Involvement in a Multidisciplinary Ischemic Stroke Team in and its Associated Cost AvoidanceTsai, Y. J. / Leu, W. J. / Lin, Y. M. / Lu, T. H. et al. | 2012
-
PCV29 Long-Term Cost-Effectiveness of Ticagrelor in Patients with Acute Coronary Syndrome in ThailandPermsuwan, U. / Yamwong, S. / Tinmanee, S. / Sritara, P. et al. | 2012
-
PCV30 Cost-Effectiveness of Cilostazol, Naftidrofuryl Oxalate, Pentoxifylline and Inositol Nicotinate for the Treatment of Intermittent Claudication in People with Peripheral Arterial Disease in the UkMeng, Y. / Squires, H. / Stevens, J. W. / Simpson, E. / Harnan, S. / Thomas, S. / Michaels, J. / Stansby, G. / O'Donnell, M. et al. | 2012
-
PGI8 Cost Effectiveness Analysis of Antibiotics Used in Gastrointestinal SurgeriesMoinuddin, S. K. / Saxena, R. / Spandana, M. / Gayatri, C. et al. | 2012
-
PGI14 Knowledge, Attitude and Practices Towards Hepatitis-B Among General Population of Quetta, PakistanHaq, N. / Hassali, M. A. / Shafie, A. A. / Saleem, F. / Aljadhey, H. / Atif, M. / Iqbal, Q. et al. | 2012
-
PIH4 Immunization Status and Families' Factors in IraqAl-lela, O. Q. / Bahari, M. B. / Alabbassi, M. G. / Salih, M. / Basher, A. Y. et al. | 2012
-
PRM20 Construction of the Markov Model for Hepatitis B Virus Related Diseases in JapanYoda, T. / Yoshioka, A. / Suzue, T. / Hirao, T. et al. | 2012
-
PRM33 Is There a Labeling Effect in the Valuation of the All-Worst Health State?Cheung, Y. B. / Gandhi, M. / Wee, H. L. / Luo, N. / Thumboo, J. et al. | 2012
-
PRM40 Applying Stratification on Time to Overcome Time-Varying Covariates Effects in Cox Proportional Hazards ModelsAbdul Aziz, S. H. / Azmi, S. / Goh, A. / Naing, N. N. et al. | 2012
-
PRM42 Multiple Criteria Decision Analysis for Health Technology AssessmentThokala, P. et al. | 2012
-
PRM43 Roles and Selection of Comparative Treatment(s) in the Assessment of New Drug Reimbursement and Pricing Application to Taiwan National Health Insurance (NHI)Shau, W. Y. / Wang, J. C. et al. | 2012
-
PRM45 Are Minimal Clinically Important Difference Measures (MCIDs) Relevant for Survival Outcomes? Introducing the MCID-CACStandfield, L. / Weston, A. et al. | 2012
-
PCN6 Lenalidomide Versus Bortezomib for Treatment of Relapsed/Refractory Multiple Myeloma (MM): A Number Needed to Treat (NNT) AnalysisKaura, S. / Dranitsaris, G. et al. | 2012
-
PCN11 Decreased Risk of Prostate Cancer in Type 2 Diabetes Patients: A Meta-Analysis of Cohort StudiesDipika, B. / Gudala, K. / Undela, K. / Pramil, T. / Bhansali, A. et al. | 2012
-
PCN17 Predicting the Potential Cost and Effects of Prophylactic HPV Vaccination in Males in ThailandAnansushatgul, J. / Vichaichanakul, K. et al. | 2012
-
PCN18 Economic Evaluation of CT Colonography (CTC) Introduction Into the Colorectal Cancer Screening Program in JapanHashimoto, Y. / Igarashi, A. / Miyake, M. / Iinuma, G. / Fukuda, T. / Tsutani, K. et al. | 2012
-
PCN21 Comparative Effectiveness and Cost-Effectiveness Assessment of Erlotinib Versus Gefitinib in First-Line Treatment of EGFR Activating Mutation Positive Non-Small Cell Lung Cancer for Hong KongLee, V. W. / Lee, V. / Schwander, B. et al. | 2012
-
PDB8 Bariatric and Metabolic Surgery in India – Efficacy and Safety of Minimally Invasive ProceduresWojciechowski, P. / Metz, L. / Mapari, J. / Jain, M. / Neoh, K. / Caban, A. / Gaweska, M. / Gomulka, A. / Plisko, R. / Wladysiuk, M. et al. | 2012
-
PDB31 The Prevalence and Burden of Comorbid Hypertension and Obesity Among Patients With Type 2 Diabetes in Urban ChinaDiBonaventura, M. D. / Liu, G. G. / Stankus, A. et al. | 2012
-
PDB35 Validation of the Problem Areas in Diabetes Questionnaire Among Patients With Type 2 Diabetes Mellitus in Singapore: a Pilot StudyRajaram, R. et al. | 2012
-
PIN1 Efficacy and Safety of Tenofovir as Compared With Alternative Treatment Options for Naive Chronic Hepatitis B – a Systematic Review and Mixed Treatment ComparisonSkarzynska-Duk, J. / Stozek, A. / Mucha, A. / Mierzejewski, P. / Kazmierski, M. / Wladysiuk, M. / Plisko, R. / Rys, P. et al. | 2012
-
PMS4 Inhibition of Carrageenan-Induced Edema by Stachys Fruticulosa Extract in RatsBakhtiarian, A. / Araghi, S. / Khanavi, M. et al. | 2012
-
PMS15 An Economic Evaluation of Denosumab in the Treatment of Postmenopausal Osteoporosis in a Taiwanese SettingChang, W. L. / Ling, Y. L. / Huang, K. C. / Tang, C. H. et al. | 2012
-
PND8 Cost Reductions Associated With the Use of Botulinum Toxin Type a for the Treatment of Urinary Incontinence in Patients With Neurogenic Detrusor OveractivityTan, J. T. / Frost, M. / Ng, K. / Kirchmann, M. et al. | 2012
-
PIN11 Pharmacotherapy of Acute Bronchitis in Clinics: Results of Pharmacoepidemical ResearchZaytsev, A. / Kulagina, I. et al. | 2012
-
PIN41 Cost-Effectiveness of Pertussis Adolescent Booster in England and Wales: A Dynamic Model Based AnalysisTerlinden, A. / Hardwick, T. / Sauboin, C. / Poirrier, J. E. et al. | 2012
-
PIN47 Cost-Effectiveness Analysis of the Primovaccination of Newborns Against Tuberculosis in SlovakiaMarusakova, E. / Bielik, J. / Frecerova, K. / Nevicka, E. / Sedlakova, D. et al. | 2012
-
PIN49 Economic Evaluation of 13-Valent Pneumococcal Vaccine in High Risk Elderly Population, From the Public Payer Perspective in BrazilCruz, R. B. / Fernandes, R. A. / Takemoto, M. / Cukier, F. N. / Fujii, R. K. / Roberts, C. S. / Presa, J. / Jardim, E. / Mould, J. et al. | 2012
-
PIN60 Critical Review of Cost-Effectiveness Analyses of Human Papillomavirus Vaccine in BoysJiang, Y. / Gauthier, A. / Pré / aud, E. / Largeron, N. et al. | 2012
-
PIN70 Cost-Effectiveness of an Individualized Approach in the Treatment of HBeAg-Negative CHB Patients With Peginterferon Alfa-2A in ItalyIannazzo, S. / Espinó / s, B. / Coco, B. / Brunetto, M. / Rossetti, F. / Caputo, A. / Bonino, F. et al. | 2012
-
PSU4 Regional Variation in Angiogram Use for Patients Who Underwent Coronary Artery Bypass Graft SurgeryBaser, O. / Burkan, A. / Baser, E. / Koselerli, R. / Ertugay, E. / Altinbas, A. et al. | 2012
-
PSU27 Liver Transplantation in Familial Amyloid Polyneuropathy in Brazil: Demographic and Clinical Data Compared to FAP World Transplant RegistryFernandes, R. A. / Amaral, L. M. / Takemoto, M. M. / Takemoto, M. / Vasconcellos, J. F. / Cukier, F. N. / Fujii, R. K. / Furlan, F. / Mould, J. et al. | 2012
-
PSU33 Characteristics and Burden of Tuberous Sclerosis Complex: Results of a Patient and Caregiver Survey in the United StatesPashos, C. L. / Rentz, A. / Liu, J. / Pelletier, C. / Prestifilippo, J. / Nakagawa, J. / Frost, M. D. / Dunn, D. W. / Wheless, J. W. et al. | 2012
-
PCN27 Analysis of Prevalence and Treatment of Multiple Myeloma in German Statutory Sick Funds Claim DataTomeczkowski, J. / Wirth, D. / Tapprich, C. / Knauf, W. et al. | 2012
-
PCN33 Progression-Free Survival as a Surrogate for Overall Survival in Metastatic Breast CancerBeauchemin, C. / Cooper, D. / Lapierre, M. E. / Yelle, L. / Lachaine, J. et al. | 2012
-
PCN38 Impact of Biomarker Testing on Clinical and Economic Outcomes in Advanced Cancer TreatmentSorensen, S. / Pan, F. / Knopf, K. B. et al. | 2012
-
PCN46 Cost-Efficacy Analysis of Licensed Drugs for the Treatment of Metastatic Castrate Resistant Prostate Cancer Post Docetaxel Based on Hospital Drug Evaluation Methodology in SpainOstalé / S. / Ruiz, P. et al. | 2012
-
PCN48 The Cost of Treating Penile Cancer in English Hospitals: Preliminary Results Using the Hospital Episodes Statistics (HES) DatabaseTempest, M. J. / Keeping, S. T. / Carroll, S. M. / Thurston, S. et al. | 2012
-
PCN68 Pharmacoeconomic Evaluation of Rituximab as Maintenance Treatment for Relapsed Follicular Lymphoma: Results of a Real-World Population Based StudyBlommestein, H. / Issa, D. / Pompen, M. / Ré / vil, C. / Hoogendoorn, M. / Joosten, P. / Huijgens, P. / Uyl-de Groot, C. et al. | 2012
-
PCN78 Cost-Effectiveness of Plerixafor Plus GCSF for Mobilization of Peripheral Blood Stem Cells in Patients With Myeloma and Lymphoma in SpainDuarte, R. F. / Pé / rez-Simó / n, J. A. / Martí / n, G. / de la Rubia, J. / Marí / n, P. / lvarez, M. A. et al. | 2012
-
PCN87 Cost Effectiveness Evaluation of Vemurafenib, an Orphan Drug for Braf Mutant Metastatic MelanomaAlva, M. / Gay, J. G. / Sanchez Kobashi, R. et al. | 2012
-
PCN90 Cost Effectiveness Analysis of Bendamustine as First Line Treatment for Chronic Lymphocytic Leukaemia in the NetherlandsVandekerckhove, S. / Holtzer-Goor, K. / Van Den Steen, D. / van Megen, Y. / Huijgens, P. / Lamotte, M. / Uyl- de Groot, C. et al. | 2012
-
PMS4 Comparing the Efficacy and Safety of Biologics for the Treatment of Rheumatoid Arthritis Patients: A Network Meta-AnalysisJanssen, K. J. / Medic, G. / Broglio, K. / Bergman, G. / Berry, S. / Sabater, F. J. / Sennfalt, K. et al. | 2012
-
PMS29 Cost Effectiveness of Adalimumab Versus Golimumab and Placebo in Ankylosing Spondylitis in ItalyMarcellusi, A. / Botteman, M. F. / Rao, S. / Cifaldi, M. / Solem, C. T. / Gitto, L. / Giannantoni, P. / Mennini, F. S. et al. | 2012
-
PMS60 The Time Horizon Matters: Exploratory Results Varying the Time Horizon in Time Trade-Off and Standard Gamble Utility ElicitationMatza, L. / Boye, K. S. / Feeny, D. H. / Bowman, L. / Johnston, J. A. / Mcdaniel, K. / Jordan, J. / Devine, M. K. / Davies, E. et al. | 2012
-
PUK1 A Swedish Prospective Observational Study to Evaluate the Impact in Quality of Life Among Previously Untreated Patients Receiving Their First Prescription of Solifenacin. (SPOQ-Study)Mattiason, A. / Persson, C. A. et al. | 2012
-
PUK2 Issues in the Systematic Review of Drugs for Rare Diseases: A Case Study of Eculizumab for aHUSKaltenthaler, E. / Rathbone, J. / Tappenden, P. / Bessey, A. / Cantrell, A. et al. | 2012
-
PUK11 Cost-Effectivness Analysis of Once Daily Versus Twice Daily Tacrolimus in Post-Renal Transplant Patients in the Czech RepublicKlimes, J. / Vocelka, M. / Dolezal, T. / Suchanková / E. et al. | 2012
-
PRM32 Development of a Post-Marketing Requirements (PMR) DatabaseMouchet, J. / Emery, M. P. / Maier, W. et al. | 2012
-
PRM37 Indirect Identification of Payer Perceptions Through Retrospective Analysis of Interview Write-UpsRuppert, A. / King, Z. / Petrie, N. / Rao, N. / Plata, A. et al. | 2012
-
PRM52 Minimum Run-Time Requirements to Reduce Monte Carlo Error in Stochastic SimulationsFoos, V. / McEwan, P. / Lloyd, A. / Palmer, J. L. / Lamotte, M. / Grant, D. et al. | 2012
-
PRM74 Cost Effectiveness of Tirofiban in Acute Coronary SyndromeLee, Y. C. / Mueller, A. / Ryder, S. / Kleijnen, J. / Armstrong, N. et al. | 2012
-
PRM80 Proportional Hazards Assumption and Its Impact on Results of Cost-Effectiveness AnalysisPochopien, M. / Zerda, I. / Gwiosda, B. / Plisko, R. et al. | 2012
-
PRM92 Exploratory Mapping of the LupusQol to the SF-6DMeacock, R. / Harrison, M. / Mcelhone, K. / Isenberg, D. / Ferenkeh-Koroma, A. / Ahmad, Y. / Bruce, I. N. / Shelmerdine, J. / Gordon, C. / Griffiths, B. et al. | 2012
-
PRM102 Validation of the Russian Version of Schizophrenia Quality of Life Questionnaire (S-QoL)Millier, A. / Khemiri, A. / Clay, E. / Antonova, S. / Auquier, P. / Aballea, S. / Toumi, M. et al. | 2012
-
PHP24 Should Pharmacist Remuneration Systems in Europe Be Reformed in Order to Increase Generic Medicine Dispensing?Dylst, P. / Vulto, A. / Simoens, S. et al. | 2012
-
PHP22 Pharmacovigilance in Qatar – a Pharmacist SurveyWilbur, K. et al. | 2012
-
PHP25 The Pharmaceutical Industry as Partner in Integrated Care Contracts - Potential Improvement or Vain Attempt? First Experiences from GermanyChase, D. P. / Amelung, V. E. et al. | 2012
-
PHP36 Analysis of the Reimbursement Decisions of the National Health Insurance Fund of Hungary (2007-2011)Botlik, O. / Kalotai, Z. et al. | 2012
-
PHP53 Identification of Factors Affecting the Medicine Expenditures in Public Hospital in MalaysiaChan, B. L. / Ibrahim, M. I. / Shafie, A. A. / Bahri, S. et al. | 2012
-
PHP62 A Novel Global Health Drug Subsidy AMFm: Assessment of Deployment in Southern GhanaDavies-Teye, B. B. et al. | 2012
-
PHP70 A Systematic Review of Hospital-at-Home Care: Cost Savings are OverestimatedGoossens, L. M. / Vemer, P. / Rutten-van Mö / lken, M. P. et al. | 2012
-
PHP93 Development of Biosimilar Mark in EU-5 and USAAmmar, H. / Ré / muzat, C. / Houas, M. / Toumi, M. et al. | 2012
-
PHP99 Identifying Major Operational Causes and Potential Remedies for Emergency Department Over-Crowding-CrowdingSchwartz, D. / Pliskin, J. S. / Ronen, B. / Goldberg, A. et al. | 2012
-
PHP101 The Implementation of Diagnostic Related Groups (DRGs) in Greece: One Move Forward to EfficiencyYfantopoulos, J. / Panagiotopoulos, P. / Letsios, A. / Karalis, G. / Thiraios, E. / Agouras, V. / Solakidi, A. / Yfantopoulos, N. et al. | 2012
-
PHP109 Practice Change in Italian Community Pharmacy: An Analysis of Managerial ImplicationVagnoni, E. / Heidari, M. et al. | 2012
-
PHP113 The Importance of Economic Evaluations in the Assessment of Reimbursement ApplicaitionsJacobi, M. / Orrskog, S. / Medin, E. et al. | 2012
-
PHP126 From Innovation to Market Access: Reimbursement Strategies of Medical Industry in Dutch Health CareDen Breejen, E. / Putters, K. / Philipszoon, F. A. et al. | 2012
-
PHP147 Early Access Programmes (EAPs): Review of the European SystemUrbinati, D. / Toumi, M. et al. | 2012
-
PHP180 Multiple Correspondence Analysis to Understand the Role of Multiprofessional Team for Shared Decision Making to Implementation in Clinical PracticeJanini, A. C. / Cuziol, M. / Battisti, R. / Baumgratz, T. D. / Levy, R. A. / Abreu, M. M. et al. | 2012
-
PHP183 The Rocky Road to Market Equilibrium – Price Regulation and Entry Liberalization in Portuguese Retail PharmacyBarros, P. P. / Martins, B. / Moura, A. et al. | 2012
-
PHP199 The Impact of the German Pharmaceutical Market Reorganisation Act (AMNOG) on the German Reference Price Market – Trends Two Years After the Introduction of the AMNOGEheberg, D. / Batscheider, A. / Lebioda, A. / Plantö / r, S. / Fricke, F. U. et al. | 2012
-
PGI6 A Budget Impact Analysis to Estimate the Economic Impact of Lactest for the Diagnosis of Hypolactasia in SpainDarba, J. / Kaskens, L. / Ramí / rez de Arellano, A. et al. | 2012
-
PGI21 Cost Effectiveness of the Combination of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Telaprevir Plus Peginterferon Alfa and Ribavirin in the Retreatment of Patients With Chronic Hepatitis C Virus Genotype I InfectionFonseca, M. / Garran, V. / Araujo, G. T. et al. | 2012
-
PMH21 Cost-Effectiveness of Intramuscular Ziprasidone for the Treatment of Acute Agitation Associated to Schizophrenia in MexicoGalindo-Suá / rez, R. M. / Peniche-Otero, G. / Herrera-Rojas, J. / Baeza-Cruz, G. / Nenclares-Portocarrero, A. / Muciñ / o-Ortega, E. et al. | 2012
-
PMH29 Cost Effectiveness of Quetiapine Extended Release Compared With Quetiapine Immediate Release in Schizophrenic Patients in MexicoPozo Urquizo, L. / Pizarro, M. / Soto, H. / Gonzalez, A. / Salazar, A. / Polanco, A. C. et al. | 2012
-
PMD9 A Comparative Assessment of Cost Implications of Novel Drug Versus Novel Device-Based Treatments for Stroke Prevention in Atrial FibrillationArmstrong, S. / Amorosi, S. / Peppa, R. / Da Deppo, L. / Garfield, S. et al. | 2012
-
PMD21 Cost Comparison of Spinal Fusion Procedures With Grafton Mixed With Local Bone Compared to Iliac Crest BoneBorgman, B. et al. | 2012
-
PMD37 Forecasting the Prevalence and Economic Burden of Atrial Fibrillation in Selected Countries, 2010-2025Rizzo, J. A. / Mallow, P. / Cirrincione, A. et al. | 2012
-
PMD35 Cost Analysis of an Implantable Loop Recorder, Reveal© XT, for the Diagnosis of Atrial Fibrillation in Patients Who Underwent Cryptogenic Stroke From the Perspective of a Tertiary Spanish HospitalBravo, Y. / Martí / B. / Grifols, M. A. et al. | 2012
-
PMD49 Cost-Effectiveness of the TLC-NOSF Dressing in Venous Leg UlcersMaunoury, F. / Motrunich, A. / Fortin, S. et al. | 2012
-
PCV2 Comparative Efficacy and Safety Analysis of Atrial Fibrillaion Patients Treated with Dabigatran in RE-LY Study (CHADS 2 Score of 3 or Greater ) Versus Rivaroxaban in ROCKET-AFRasty, S. / Soliman, W. / Taheri, R. et al. | 2012
-
PCV3 Prevalence, Associated Comorbidities and Treatment Patterns Among Chronic Kidney Disease Patients: An Analysis Using UK GPRD DataJick, S. / Hagberg, K. W. / O'Donoghue, D. / Jameson, K. / Ambegaonkar, B. M. et al. | 2012
-
PCV8 Assessment of 30-Day Rehospitalization for Acute Myocardial Infarction in Patients with Acute Coronary Syndrome Who Received Percutaneous Coronary Intervention: A Comparative Effectiveness Study of Clopidogrel and PrasugrelBae, J. P. / Faries, D. E. / Ernst, F. R. / Lipkin, C. / Zhao, Z. / Moretz, C. et al. | 2012
-
PCV14 Colesevelam for the Treatment of Hyperlipidemia: A Retrospective ‘Real-World' Analysis From an Integrated Health SystemRomanelli, R. / Leahy, A. / Jukes, T. / Ye, X. / Luan, A. / Ishisaka, D. et al. | 2012
-
PCV29 Health Care Resource Utilization and Costs of Cardioembolic Stroke in the Region of Madrid, Spain: Preliminary Results of CODICE Studyde Andres, F. / Vivancos, J. / Barriga, F. J. / Diaz, F. / Izquierdo, L. / Ortega, M. A. / Castillo, L. / Ximenez-Carrillo, A. / Martin, M. P. / Gomez-Escalonilla, C. I. et al. | 2012
-
PCV37 VIP Study: Incremental Cost During Hospitalization After Total Knee and Hip Arthroplasty in Brazilian Health Care ServicesMainine, S. / Nita, M. E. / Scheinberg, M. / Vasconcelos, P. / Guerra, R. / Takemoto, M. / Fujii, R. K. / Mould, J. F. / Loures-Vale, A. A. / Presa, J. et al. | 2012
-
PCV56 Cost Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Patients Not at LDL Cholesterol Treatment Goal in BrazilAraujo, G. T. / Fonseca, M. / Etto, H. / Davies, G. M. / Hsu, T. Y. et al. | 2012
-
PCV61 Pharmacoeconomic Evaluation of Olmesartan, Losartan and Valsartan in Treatment of Essential Arterial HypertensionGorokhova, S. G. / Ryazhenov, V. V. et al. | 2012
-
PCV98 Health Related Quality of Life and Age in Hypertensive Patients: Self-Perception and Evaluation by Professionals. The Equality StudyFont, B. / Lahoz, R. / Salazar, J. / Roca-Cusachs, A. / Abellá / n, J. / Ruí / z, D. et al. | 2012
-
PR1 Comparison of Cancer Drug Prices in the United States and the UkAggarwal, S. et al. | 2012
-
QL3 Simulations of Adaptive Measurement of Change for Health Related Quality of Life Assesments in Chronic ConditionsRebollo, P. / Castejó / n, N. / Cuervo, J. / Rodrí / guez, A. / Diaz, H. et al. | 2012
-
UT4 Health Utility Scores in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Response to Stimulant TreatmentSetyawan, J. / Banaschewski, T. / Hodgkins, P. / Lecendreux, M. / Johnson, M. / Zuddas, A. / Bloomfield, R. / Coghill, D. R. et al. | 2012
-
PHP6 Comparing the Effectivness of Different Educational Programs for Children on Appropriate Antibiotic UseSoleymani, F. / Mohamadhosseini, N. et al. | 2012
-
PRM108 Reliability, Validity, and Ability to Detect Change of the Fact-an for Use in Patients With Anaemia Associated With Chronic Kidney DiseaseWiklund, I. / Jin, Y. / Chen, W. H. / van Nooten, F. / Garcia-Hernandez, A. / Holmstrom, S. et al. | 2012
-
PRM121 Burden of Osteoarthritis: Development of a QuestionnaireBertin, P. / Coudert, T. / Rannou, F. / Grange, L. / Taieb, C. et al. | 2012
-
PRM137 Reminders Help Improving Completion Rate of Home-Administered Lifestyle QuestionnairesWiederkehr, S. / Seux, M. / Faure, C. / Fournie, X. et al. | 2012
-
PRM147 Comparison of Indirect and Mixed Treatment Comparison (MTC) Meta-Analysis Techniques Used in the Evaluation of New Protease Inhibitors for the Treatment of Chronic Hepatitis CLion, M. / Humphreys, S. / Mills, E. / O'Regan, C. et al. | 2012
-
PRM151 Collapsibility and Censoring: What's the Bias in Estimated Survival Time?Goossens, L. M. / van Gils, C. W. / Redekop, W. K. et al. | 2012
-
PRM154 Source Data Verification – A Survey of Current PracticeVelthuis, E. J. / Malka, E. S. / Richards, M. S. / Orr, M. / Sernau, T. et al. | 2012
-
PRM163 The Use of Expected Value of Perfect Information Analysis Within Economic Evaluations and Health Technology Assessments in the UKAlmond, C. / Brereton, N. J. et al. | 2012
-
PRM175 Identification and Translation of Culturally Bound Terms in Patient Reported Outcome MeasuresSimpson, H. / Two, R. / Verjee-Lorenz, A. / Clayson, D. et al. | 2012
-
PDB11 A Large-Scale Longitudinal Population-Based Study of Risk Reduction of Cardiovascular Complications in Patients on Bolus Insulin AnaloguesCammarota, S. / Bruzzese, D. / Catapano, A. L. / Citarella, A. / De luca, L. / Manzoli, L. / Masulli, M. / Flacco, M. E. / Menditto, E. / Mezzetti, A. et al. | 2012
-
PDB39 Evaluation of the Long-Term Clinical and Economic Impact of a 1% HbA1C Reduction in Patients With Type 2 Diabetes in IndonesiaTodorova, L. / Soewondo, P. / Hunt, B. / Suastika, K. et al. | 2012
-
PDB48 Health Care Resources Utilization and Costs Associated With the Management of Patients With Acromegaly: An Analysis Based on the Ramq DatabaseLachaine, J. / Serri, O. / Beauchemin, C. / Hurry, M. / Koch, C. et al. | 2012
-
PDB54 Systematic Literature Review of Utility Values Associated With Type 2 Diabetes-Related ComplicationsBeaudet, A. / Clegg, J. P. / Lloyd, A. et al. | 2012
-
PDB60 Preliminary Results on the Reliability and Validity of the Worry Subscale of the Hypoglycaemic Fear Survey-II for Assessing the Impact of Fear for Hypoglycemia on the Health-Related Quality of Life of Type 2 Diabetes Mellitus Patients in SpainFont, B. / Lahoz, R. / Roldan, C. / Jó / dar, E. / lvarez, F. / vila, L. / Palomares, R. et al. | 2012
-
PDB77 Characteristics of Patients With Diabetes in Southwestern Ontario, CanadaPetrella, R. J. / Tarride, J. E. / O'Reilly, D. / Xie, F. / Goeree, R. et al. | 2012
-
PSY16 Effect of the Anti-Tumor Necrosis Factor Adalimumab on Work Productivity in Patients With Chronic Immune-Mediated Inflammatory Diseases: Literature ReviewGranados, D. / Depont, F. / Chevreul, K. et al. | 2012
-
PSY36 Changes in Pain Intensity and Health Related Quality of Life (QoL) in Patients With Peripheral Neuropathic Pain After a Single Treatment of 8% Capsaicin Patch – Results From a Swedish 12 Week Prospective Observational StudyHansson, P. / Magnusson, K. / Persson, C. A. et al. | 2012
-
PSY44 A Cost Effectiveness Model for the Myeloplastic Disease in Greece. Azacitidine Versus Conventional Care RegimensYfantopoulos, J. / Kritikou, P. et al. | 2012
-
PSY48 Developing a National Outcomes Treatment Registry for Hepatitis C Patients in the Era of the DAAsO'Leary, A. / Norris, S. / Bergin, C. / Kieran, J. / Walsh, C. / Barry, M. et al. | 2012
-
PHS47 Cost-Utility Analysis of Rotigotine in Restless Legs Syndrome from the NHS Scotland PerspectiveBenhaddi, H. / Lundie, G. et al. | 2012
-
PHS55 Inequalities and Avoidable Costs of Imaging Test in the Diagnosis and Monitoring of Patients With Stroke in the Canary IslandsValcá / rcel-Nazco, C. / Castilla-Rodrí / guez, I. / Ramos-goñ / i, J. / Serrano-aguilar, P. et al. | 2012
-
PHS56 Evaluation of Telemedicine Program (ITHACA): Innovation in the Treatment of Arterial Hypertension Increasing the Compliance and AdherenceSicras-mainar, A. / Ibañ / ez, J. / Frias, X. / Bulto, C. / Costa, A. / Majos, N. / Lahoz, R. et al. | 2012